Project
Illumina Body Map 2 (GSE30611)
Navigation
Downloads
Results for SP1
Z-value: 2.02
Motif logo
Transcription factors associated with SP1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
SP1
|
ENSG00000185591.10 | Sp1 transcription factor |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| SP1 | hg38_v1_chr12_+_53381260_53381302 | 0.19 | 3.0e-01 | Click! |
Activity profile of SP1 motif
Sorted Z-values of SP1 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of SP1
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.0 | 6.1 | GO:2000657 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 1.8 | 5.3 | GO:1903572 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 1.7 | 6.6 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 1.5 | 4.6 | GO:1904692 | positive regulation of type B pancreatic cell proliferation(GO:1904692) |
| 1.5 | 4.5 | GO:1903515 | calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
| 1.4 | 4.3 | GO:1990709 | presynaptic active zone organization(GO:1990709) |
| 1.4 | 17.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 1.4 | 9.5 | GO:0051012 | microtubule sliding(GO:0051012) |
| 1.3 | 3.8 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 1.2 | 5.0 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 1.2 | 6.2 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 1.2 | 6.1 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 1.2 | 4.8 | GO:0072134 | nephrogenic mesenchyme morphogenesis(GO:0072134) |
| 1.2 | 3.5 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 1.1 | 4.4 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 1.1 | 6.5 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 1.1 | 7.6 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 1.1 | 3.2 | GO:0036304 | umbilical cord morphogenesis(GO:0036304) umbilical cord development(GO:0061027) |
| 1.1 | 3.2 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 1.0 | 7.8 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 0.9 | 0.9 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
| 0.9 | 2.7 | GO:0015881 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.9 | 0.9 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 0.9 | 3.6 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.9 | 2.7 | GO:0097274 | urea homeostasis(GO:0097274) |
| 0.9 | 12.6 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.9 | 4.3 | GO:1901090 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.8 | 2.5 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.8 | 5.0 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.8 | 4.2 | GO:0097195 | pilomotor reflex(GO:0097195) |
| 0.8 | 2.5 | GO:0007037 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 0.8 | 1.7 | GO:2000793 | cell proliferation involved in heart valve development(GO:2000793) |
| 0.8 | 5.8 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.8 | 2.5 | GO:0051041 | positive regulation of calcium-independent cell-cell adhesion(GO:0051041) |
| 0.8 | 3.3 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.8 | 3.2 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.8 | 0.8 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.8 | 0.8 | GO:0021718 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.8 | 5.5 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
| 0.8 | 2.3 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.8 | 3.9 | GO:0003068 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.8 | 5.4 | GO:0030421 | defecation(GO:0030421) |
| 0.8 | 3.1 | GO:1903892 | negative regulation of ATF6-mediated unfolded protein response(GO:1903892) |
| 0.8 | 1.5 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.8 | 4.5 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.8 | 4.5 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.8 | 3.0 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
| 0.7 | 2.9 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.7 | 2.9 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.7 | 1.5 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.7 | 2.2 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.7 | 3.6 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
| 0.7 | 1.4 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
| 0.7 | 2.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.7 | 2.1 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
| 0.7 | 2.8 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 0.7 | 4.9 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.7 | 3.5 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.7 | 0.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 0.7 | 4.1 | GO:0015862 | uridine transport(GO:0015862) |
| 0.7 | 6.0 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.7 | 0.7 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 0.7 | 2.0 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
| 0.6 | 1.9 | GO:0090340 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 0.6 | 6.5 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.6 | 5.2 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.6 | 14.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.6 | 1.9 | GO:0005999 | xylulose biosynthetic process(GO:0005999) |
| 0.6 | 3.7 | GO:1902162 | platelet alpha granule organization(GO:0070889) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.6 | 4.9 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
| 0.6 | 1.8 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.6 | 3.0 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
| 0.6 | 4.8 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 0.6 | 4.7 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 0.6 | 6.4 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.6 | 3.5 | GO:0038016 | insulin receptor internalization(GO:0038016) |
| 0.6 | 3.5 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 0.6 | 1.7 | GO:0060178 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.6 | 1.7 | GO:0051463 | negative regulation of cortisol secretion(GO:0051463) |
| 0.6 | 1.7 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 0.6 | 1.7 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.6 | 7.2 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.6 | 1.7 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.6 | 3.9 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.6 | 9.4 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
| 0.5 | 4.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.5 | 4.3 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.5 | 6.0 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.5 | 3.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.5 | 1.1 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.5 | 8.5 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.5 | 1.1 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.5 | 1.1 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.5 | 1.1 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 0.5 | 1.6 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.5 | 2.1 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.5 | 1.6 | GO:0014736 | negative regulation of muscle atrophy(GO:0014736) response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 0.5 | 0.5 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.5 | 3.1 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
| 0.5 | 2.1 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.5 | 2.6 | GO:0034241 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
| 0.5 | 2.6 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.5 | 3.1 | GO:0001757 | somite specification(GO:0001757) |
| 0.5 | 1.0 | GO:0070836 | caveola assembly(GO:0070836) |
| 0.5 | 5.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.5 | 7.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.5 | 5.0 | GO:0008050 | female courtship behavior(GO:0008050) |
| 0.5 | 1.5 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.5 | 1.0 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.5 | 2.0 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.5 | 2.0 | GO:0070426 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 0.5 | 4.4 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.5 | 3.5 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
| 0.5 | 2.9 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.5 | 1.0 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.5 | 1.0 | GO:1902617 | response to fluoride(GO:1902617) |
| 0.5 | 1.4 | GO:0100057 | regulation of phenotypic switching by transcription from RNA polymerase II promoter(GO:0100057) regulation of hydrogen sulfide biosynthetic process(GO:1904826) positive regulation of hydrogen sulfide biosynthetic process(GO:1904828) |
| 0.5 | 0.5 | GO:0051040 | regulation of calcium-independent cell-cell adhesion(GO:0051040) |
| 0.5 | 3.3 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.5 | 3.8 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.5 | 7.0 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.5 | 1.4 | GO:1903576 | response to L-arginine(GO:1903576) |
| 0.5 | 1.9 | GO:0060254 | regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
| 0.5 | 2.8 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.5 | 1.8 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.5 | 9.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.5 | 0.5 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.5 | 0.5 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.5 | 1.4 | GO:0090176 | microtubule cytoskeleton organization involved in establishment of planar polarity(GO:0090176) |
| 0.5 | 2.7 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.5 | 5.5 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.5 | 2.7 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
| 0.5 | 1.4 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
| 0.5 | 0.5 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.5 | 1.8 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.5 | 0.5 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.5 | 1.4 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.4 | 2.2 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.4 | 1.8 | GO:0060596 | mammary placode formation(GO:0060596) |
| 0.4 | 1.3 | GO:0099538 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.4 | 0.4 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
| 0.4 | 0.9 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 0.4 | 1.3 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.4 | 2.2 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.4 | 1.8 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.4 | 0.4 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
| 0.4 | 1.3 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
| 0.4 | 1.7 | GO:0061573 | endoplasmic reticulum polarization(GO:0061163) actin filament bundle retrograde transport(GO:0061573) actin filament bundle distribution(GO:0070650) |
| 0.4 | 7.3 | GO:0042420 | dopamine catabolic process(GO:0042420) |
| 0.4 | 7.8 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
| 0.4 | 2.2 | GO:0019413 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate biosynthetic process(GO:0019542) |
| 0.4 | 8.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.4 | 3.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.4 | 0.4 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.4 | 1.7 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.4 | 1.7 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.4 | 2.5 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 0.4 | 1.7 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.4 | 0.4 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.4 | 1.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.4 | 5.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.4 | 0.4 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.4 | 2.0 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.4 | 2.4 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.4 | 2.9 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
| 0.4 | 2.8 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.4 | 4.0 | GO:1902846 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 0.4 | 4.4 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.4 | 2.4 | GO:2000984 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.4 | 0.4 | GO:0060157 | urinary bladder development(GO:0060157) |
| 0.4 | 0.4 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.4 | 2.4 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.4 | 3.6 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
| 0.4 | 1.2 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
| 0.4 | 1.2 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.4 | 3.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.4 | 3.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.4 | 2.0 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.4 | 1.6 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.4 | 4.7 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.4 | 1.6 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
| 0.4 | 3.1 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 0.4 | 3.5 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.4 | 1.9 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 0.4 | 0.4 | GO:1904387 | cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 0.4 | 1.2 | GO:0007402 | ganglion mother cell fate determination(GO:0007402) |
| 0.4 | 1.2 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.4 | 2.7 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 0.4 | 1.5 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 0.4 | 2.3 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
| 0.4 | 3.4 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.4 | 1.5 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.4 | 0.4 | GO:0051695 | actin filament uncapping(GO:0051695) |
| 0.4 | 2.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.4 | 1.5 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.4 | 1.1 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.4 | 0.4 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.4 | 1.1 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.4 | 3.8 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.4 | 0.8 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.4 | 3.0 | GO:0051935 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.4 | 0.4 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 0.4 | 0.7 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.4 | 1.1 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
| 0.4 | 1.1 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.4 | 3.7 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.4 | 1.9 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.4 | 1.5 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
| 0.4 | 2.2 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
| 0.4 | 0.4 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
| 0.4 | 1.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.4 | 1.1 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
| 0.4 | 1.1 | GO:0035445 | borate transmembrane transport(GO:0035445) borate transport(GO:0046713) |
| 0.4 | 2.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.4 | 1.8 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.4 | 1.8 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
| 0.4 | 2.5 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 0.4 | 1.1 | GO:2000777 | cellular response to caloric restriction(GO:0061433) negative regulation of oligodendrocyte progenitor proliferation(GO:0070446) positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.4 | 2.5 | GO:1901963 | glial cell fate determination(GO:0007403) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901963) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
| 0.4 | 4.7 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
| 0.4 | 1.1 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 0.4 | 1.1 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.4 | 3.9 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.4 | 0.4 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
| 0.4 | 2.8 | GO:0021816 | extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
| 0.4 | 1.8 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.4 | 0.4 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.4 | 1.4 | GO:0033606 | B cell receptor transport within lipid bilayer(GO:0032595) B cell receptor transport into membrane raft(GO:0032597) protein transport out of membrane raft(GO:0032599) chemokine receptor transport out of membrane raft(GO:0032600) negative regulation of transforming growth factor beta3 production(GO:0032913) chemokine receptor transport within lipid bilayer(GO:0033606) |
| 0.4 | 3.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.4 | 1.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.4 | 2.5 | GO:0090166 | Golgi disassembly(GO:0090166) |
| 0.3 | 0.3 | GO:0009106 | lipoate metabolic process(GO:0009106) |
| 0.3 | 3.1 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.3 | 5.6 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.3 | 0.7 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
| 0.3 | 1.4 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
| 0.3 | 1.4 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 0.3 | 1.4 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 0.3 | 1.0 | GO:1990172 | G-protein coupled receptor catabolic process(GO:1990172) |
| 0.3 | 0.3 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) |
| 0.3 | 0.7 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 0.3 | 0.7 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.3 | 0.7 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.3 | 1.0 | GO:0036323 | vascular endothelial growth factor receptor-1 signaling pathway(GO:0036323) |
| 0.3 | 1.0 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.3 | 7.5 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.3 | 1.0 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 0.3 | 2.0 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.3 | 14.9 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.3 | 1.0 | GO:0035668 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.3 | 2.4 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.3 | 5.7 | GO:0015871 | choline transport(GO:0015871) |
| 0.3 | 1.7 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
| 0.3 | 0.3 | GO:0034059 | response to anoxia(GO:0034059) |
| 0.3 | 1.3 | GO:1904980 | positive regulation of endosome organization(GO:1904980) |
| 0.3 | 5.3 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.3 | 1.7 | GO:0043375 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) regulation of retinal cell programmed cell death(GO:0046668) negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.3 | 1.0 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.3 | 1.0 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
| 0.3 | 1.3 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
| 0.3 | 1.3 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
| 0.3 | 1.3 | GO:0046066 | dGDP metabolic process(GO:0046066) |
| 0.3 | 0.6 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.3 | 1.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 0.3 | 1.6 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.3 | 0.3 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
| 0.3 | 1.9 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
| 0.3 | 3.8 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.3 | 0.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.3 | 1.6 | GO:0035645 | enteric smooth muscle cell differentiation(GO:0035645) |
| 0.3 | 5.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.3 | 0.9 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.3 | 2.8 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.3 | 2.2 | GO:0060356 | leucine import(GO:0060356) |
| 0.3 | 9.5 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.3 | 1.8 | GO:0060613 | fat pad development(GO:0060613) |
| 0.3 | 3.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.3 | 6.7 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.3 | 2.7 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.3 | 0.3 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.3 | 0.9 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.3 | 0.3 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
| 0.3 | 0.3 | GO:0071284 | cellular response to lead ion(GO:0071284) |
| 0.3 | 1.2 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 0.3 | 2.7 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
| 0.3 | 3.9 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.3 | 7.2 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.3 | 3.9 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
| 0.3 | 1.2 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.3 | 1.8 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 0.3 | 1.8 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
| 0.3 | 3.9 | GO:0009414 | response to water deprivation(GO:0009414) |
| 0.3 | 1.8 | GO:0035900 | response to isolation stress(GO:0035900) |
| 0.3 | 1.8 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
| 0.3 | 3.5 | GO:0048625 | myoblast fate commitment(GO:0048625) |
| 0.3 | 1.8 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.3 | 3.5 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.3 | 0.3 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) negative regulation of neuromuscular junction development(GO:1904397) |
| 0.3 | 1.5 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.3 | 0.9 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.3 | 1.5 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
| 0.3 | 2.9 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.3 | 1.4 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.3 | 1.2 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
| 0.3 | 0.9 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) |
| 0.3 | 0.3 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
| 0.3 | 2.9 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.3 | 0.9 | GO:0070141 | response to UV-A(GO:0070141) |
| 0.3 | 3.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.3 | 3.4 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.3 | 0.6 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 0.3 | 2.0 | GO:0031622 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
| 0.3 | 3.1 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.3 | 1.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.3 | 2.0 | GO:2000582 | regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.3 | 1.4 | GO:0035106 | operant conditioning(GO:0035106) |
| 0.3 | 2.0 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.3 | 3.4 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
| 0.3 | 2.3 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 0.3 | 1.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.3 | 0.3 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
| 0.3 | 1.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.3 | 10.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.3 | 1.4 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.3 | 2.5 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.3 | 0.3 | GO:0048308 | organelle inheritance(GO:0048308) |
| 0.3 | 2.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.3 | 3.3 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.3 | 1.7 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.3 | 2.2 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
| 0.3 | 1.4 | GO:0072144 | glomerular mesangial cell development(GO:0072144) |
| 0.3 | 0.5 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.3 | 3.8 | GO:0071316 | cellular response to nicotine(GO:0071316) |
| 0.3 | 5.7 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.3 | 0.5 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
| 0.3 | 0.8 | GO:0042040 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.3 | 1.1 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
| 0.3 | 7.0 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.3 | 0.8 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.3 | 1.1 | GO:0048749 | compound eye development(GO:0048749) |
| 0.3 | 9.3 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.3 | 1.8 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.3 | 0.8 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
| 0.3 | 3.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.3 | 2.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.3 | 7.0 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.3 | 5.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.3 | 0.3 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) negative regulation of hormone biosynthetic process(GO:0032353) |
| 0.3 | 3.4 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
| 0.3 | 2.3 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
| 0.3 | 3.6 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
| 0.3 | 1.0 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 0.3 | 1.3 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
| 0.3 | 0.8 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.3 | 0.8 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 0.3 | 1.8 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 0.3 | 1.8 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.3 | 0.5 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 0.3 | 0.5 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.3 | 1.3 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.2 | 5.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.2 | 1.2 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.2 | 0.5 | GO:0097491 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
| 0.2 | 2.0 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.2 | 5.5 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.2 | 0.5 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
| 0.2 | 0.5 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.2 | 0.7 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.2 | 0.7 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.2 | 1.7 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.2 | 1.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.2 | 1.5 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 0.2 | 9.0 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
| 0.2 | 1.9 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
| 0.2 | 1.2 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.2 | 4.9 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
| 0.2 | 6.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.2 | 2.4 | GO:1904179 | regulation of adipose tissue development(GO:1904177) positive regulation of adipose tissue development(GO:1904179) |
| 0.2 | 0.5 | GO:0072008 | glomerular mesangial cell differentiation(GO:0072008) |
| 0.2 | 3.9 | GO:0072386 | plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.2 | 4.1 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.2 | 0.5 | GO:0072190 | ureter urothelium development(GO:0072190) |
| 0.2 | 0.7 | GO:0034183 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 0.2 | 1.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.2 | 3.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
| 0.2 | 4.1 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.2 | 1.0 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.2 | 1.7 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 0.2 | 1.7 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.2 | 1.4 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.2 | 1.9 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.2 | 0.9 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.2 | 1.7 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.2 | 1.9 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.2 | 0.2 | GO:1904640 | response to methionine(GO:1904640) |
| 0.2 | 1.7 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.2 | 4.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.2 | 0.7 | GO:0015734 | taurine transport(GO:0015734) |
| 0.2 | 0.5 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.2 | 0.7 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.2 | 0.5 | GO:0019520 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.2 | 4.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.2 | 0.9 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
| 0.2 | 1.6 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 0.2 | 0.5 | GO:0042335 | cuticle development(GO:0042335) |
| 0.2 | 0.9 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
| 0.2 | 1.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
| 0.2 | 1.6 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
| 0.2 | 0.7 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.2 | 1.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.2 | 0.9 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.2 | 0.2 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
| 0.2 | 0.2 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
| 0.2 | 0.7 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 0.2 | 1.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 0.2 | 0.9 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.2 | 0.7 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.2 | 0.4 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.2 | 0.9 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.2 | 1.1 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.2 | 3.5 | GO:0009629 | response to gravity(GO:0009629) |
| 0.2 | 0.4 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.2 | 2.6 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.2 | 1.8 | GO:0036337 | Fas signaling pathway(GO:0036337) |
| 0.2 | 1.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.2 | 0.2 | GO:1904429 | regulation of t-circle formation(GO:1904429) |
| 0.2 | 0.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.2 | 8.1 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.2 | 3.7 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.2 | 2.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.2 | 3.2 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.2 | 0.2 | GO:1904868 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.2 | 0.6 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.2 | 0.4 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.2 | 1.7 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.2 | 3.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.2 | 0.2 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.2 | 0.8 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.2 | 0.8 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.2 | 2.3 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.2 | 2.1 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
| 0.2 | 1.5 | GO:0061439 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
| 0.2 | 0.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.2 | 0.8 | GO:0006169 | adenosine salvage(GO:0006169) dATP biosynthetic process(GO:0006175) purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) |
| 0.2 | 1.3 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.2 | 1.0 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
| 0.2 | 0.8 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 0.2 | 0.6 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.2 | 1.0 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.2 | 1.2 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
| 0.2 | 4.1 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.2 | 2.1 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.2 | 2.7 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
| 0.2 | 0.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
| 0.2 | 3.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.2 | 1.2 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
| 0.2 | 1.0 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.2 | 2.2 | GO:0007521 | muscle cell fate determination(GO:0007521) |
| 0.2 | 4.1 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.2 | 1.4 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
| 0.2 | 0.6 | GO:1990535 | neuron projection maintenance(GO:1990535) |
| 0.2 | 3.6 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
| 0.2 | 4.4 | GO:0046324 | regulation of glucose import(GO:0046324) |
| 0.2 | 0.8 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.2 | 1.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.2 | 0.8 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.2 | 0.2 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.2 | 0.8 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 0.2 | 0.6 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.2 | 1.0 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.2 | 0.8 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.2 | 6.1 | GO:0097205 | renal filtration(GO:0097205) |
| 0.2 | 2.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.2 | 0.6 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.2 | 0.8 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.2 | 9.7 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
| 0.2 | 1.0 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.2 | 0.6 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
| 0.2 | 3.3 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.2 | 1.5 | GO:1901355 | response to rapamycin(GO:1901355) |
| 0.2 | 0.8 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.2 | 2.9 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.2 | 1.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.2 | 1.3 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.2 | 1.3 | GO:0019343 | cysteine biosynthetic process from serine(GO:0006535) cysteine biosynthetic process via cystathionine(GO:0019343) |
| 0.2 | 1.5 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.2 | 1.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.2 | 0.4 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.2 | 7.6 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.2 | 3.4 | GO:0010561 | negative regulation of glycoprotein biosynthetic process(GO:0010561) |
| 0.2 | 11.9 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
| 0.2 | 0.6 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 0.2 | 2.3 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.2 | 1.7 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.2 | 1.5 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
| 0.2 | 1.7 | GO:0030578 | PML body organization(GO:0030578) |
| 0.2 | 0.6 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.2 | 0.9 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.2 | 1.5 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
| 0.2 | 1.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.2 | 1.7 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.2 | 0.9 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.2 | 0.7 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.2 | 0.4 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 0.2 | 0.7 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
| 0.2 | 2.0 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.2 | 0.4 | GO:0021730 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) |
| 0.2 | 0.7 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.2 | 0.9 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
| 0.2 | 0.2 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.2 | 1.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.2 | 0.5 | GO:0044533 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
| 0.2 | 1.3 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.2 | 2.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.2 | 3.2 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.2 | 1.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.2 | 1.3 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.2 | 0.9 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.2 | 1.8 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.2 | 0.7 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 0.2 | 1.6 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.2 | 3.6 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.2 | 1.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.2 | 0.5 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
| 0.2 | 0.9 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
| 0.2 | 2.5 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.2 | 4.3 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.2 | 1.2 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.2 | 1.6 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.2 | 0.5 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.2 | 0.7 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.2 | 0.4 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.2 | 1.9 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.2 | 0.2 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 0.2 | 0.4 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
| 0.2 | 0.7 | GO:0006531 | aspartate metabolic process(GO:0006531) |
| 0.2 | 1.1 | GO:0032099 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.2 | 0.4 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
| 0.2 | 2.3 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.2 | 0.9 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
| 0.2 | 0.4 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.2 | 1.4 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
| 0.2 | 0.3 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.2 | 0.9 | GO:1903613 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 0.2 | 0.7 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.2 | 0.3 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.2 | 2.7 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.2 | 0.2 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
| 0.2 | 0.3 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.2 | 3.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.2 | 1.7 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.2 | 0.2 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
| 0.2 | 0.7 | GO:0010044 | response to aluminum ion(GO:0010044) |
| 0.2 | 1.2 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 0.2 | 0.7 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.2 | 1.0 | GO:0042819 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 biosynthetic process(GO:0042819) |
| 0.2 | 0.7 | GO:1903400 | L-arginine transmembrane transport(GO:1903400) |
| 0.2 | 0.8 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.2 | 0.2 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
| 0.2 | 0.2 | GO:0043201 | response to leucine(GO:0043201) |
| 0.2 | 0.8 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.2 | 0.2 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 0.2 | 1.0 | GO:0015692 | lead ion transport(GO:0015692) |
| 0.2 | 0.5 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.2 | 0.7 | GO:0035498 | carnosine metabolic process(GO:0035498) |
| 0.2 | 2.2 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 0.2 | 1.3 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.2 | 2.8 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.2 | 0.8 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.2 | 0.3 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 0.2 | 1.0 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.2 | 0.7 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.2 | 1.2 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 0.2 | 0.5 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.2 | 1.3 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.2 | 0.7 | GO:0035853 | chromosome passenger complex localization to spindle midzone(GO:0035853) |
| 0.2 | 1.1 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.2 | 0.8 | GO:0042853 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.2 | 1.6 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.2 | 5.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
| 0.2 | 0.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.2 | 2.1 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.2 | 3.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.2 | 0.6 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.2 | 1.9 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.2 | 1.1 | GO:0018032 | protein amidation(GO:0018032) |
| 0.2 | 1.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.2 | 0.5 | GO:0048840 | otolith development(GO:0048840) |
| 0.2 | 1.0 | GO:0015853 | adenine transport(GO:0015853) |
| 0.2 | 5.0 | GO:1903432 | regulation of TORC1 signaling(GO:1903432) |
| 0.2 | 1.8 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.2 | 0.3 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.2 | 0.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.2 | 1.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.2 | 1.6 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.2 | 8.7 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.2 | 0.9 | GO:0001878 | response to yeast(GO:0001878) |
| 0.2 | 0.5 | GO:0071962 | mitotic sister chromatid cohesion, centromeric(GO:0071962) |
| 0.2 | 1.3 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.2 | 0.6 | GO:0033197 | response to vitamin E(GO:0033197) |
| 0.2 | 0.3 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.2 | 2.0 | GO:0050872 | white fat cell differentiation(GO:0050872) |
| 0.2 | 0.5 | GO:0061181 | regulation of chondrocyte development(GO:0061181) negative regulation of chondrocyte development(GO:0061182) |
| 0.2 | 0.5 | GO:1902910 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 0.2 | 1.1 | GO:1902075 | cellular response to salt(GO:1902075) |
| 0.2 | 1.2 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
| 0.2 | 1.6 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.2 | 0.3 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.2 | 1.1 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
| 0.2 | 1.4 | GO:0007512 | adult heart development(GO:0007512) |
| 0.2 | 0.9 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.2 | 0.8 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
| 0.2 | 11.3 | GO:0005977 | glycogen metabolic process(GO:0005977) |
| 0.2 | 0.9 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.2 | 1.7 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.2 | 0.6 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.2 | 1.1 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
| 0.2 | 0.5 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.2 | 0.9 | GO:0036018 | cellular response to erythropoietin(GO:0036018) |
| 0.2 | 1.7 | GO:0032288 | myelin assembly(GO:0032288) |
| 0.2 | 0.6 | GO:0021564 | vagus nerve development(GO:0021564) |
| 0.2 | 2.9 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.2 | 0.6 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.2 | 0.6 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.2 | 5.3 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.2 | 0.6 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
| 0.2 | 2.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.2 | 0.6 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.2 | 0.9 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
| 0.2 | 1.7 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.2 | 0.9 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.2 | 0.2 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 0.2 | 4.8 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.2 | 0.8 | GO:0009213 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.2 | 0.5 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
| 0.2 | 0.2 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
| 0.1 | 0.9 | GO:0015820 | leucine transport(GO:0015820) |
| 0.1 | 0.7 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.1 | 0.9 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 0.1 | 9.1 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
| 0.1 | 1.2 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 | 0.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 | 0.3 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.1 | 1.2 | GO:1902074 | response to salt(GO:1902074) |
| 0.1 | 3.0 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 | 1.0 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 | 1.0 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.1 | 0.1 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.1 | 0.6 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.1 | 0.9 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.1 | 0.7 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.1 | 0.4 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 0.1 | 0.4 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.1 | 0.4 | GO:0072135 | kidney mesenchymal cell proliferation(GO:0072135) metanephric mesenchymal cell proliferation involved in metanephros development(GO:0072136) |
| 0.1 | 1.3 | GO:0014909 | smooth muscle cell migration(GO:0014909) |
| 0.1 | 1.2 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.1 | 2.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
| 0.1 | 0.3 | GO:0090270 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
| 0.1 | 2.3 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.1 | 1.0 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.1 | 0.3 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.1 | 0.4 | GO:1903215 | regulation of mRNA modification(GO:0090365) negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.1 | 0.6 | GO:0071362 | cellular response to ether(GO:0071362) |
| 0.1 | 0.3 | GO:0030104 | water homeostasis(GO:0030104) |
| 0.1 | 2.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.1 | 0.1 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.1 | 0.8 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.1 | 0.4 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 0.1 | 2.8 | GO:0030497 | fatty acid elongation(GO:0030497) |
| 0.1 | 3.5 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.1 | 1.0 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.1 | 2.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 | 1.8 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.1 | 1.0 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.1 | 0.6 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.1 | 0.7 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
| 0.1 | 1.9 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.1 | 3.4 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.1 | 1.4 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.1 | 1.1 | GO:0071872 | cellular response to epinephrine stimulus(GO:0071872) |
| 0.1 | 0.1 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
| 0.1 | 3.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.1 | 1.0 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.1 | 9.1 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
| 0.1 | 0.3 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.1 | 2.8 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.1 | 4.3 | GO:0014044 | Schwann cell development(GO:0014044) |
| 0.1 | 0.9 | GO:0072186 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) |
| 0.1 | 0.5 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.1 | 1.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.1 | 2.3 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
| 0.1 | 1.2 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.1 | 0.3 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.1 | 0.9 | GO:0007622 | rhythmic behavior(GO:0007622) |
| 0.1 | 0.7 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.1 | 2.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 | 0.4 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
| 0.1 | 2.5 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) |
| 0.1 | 0.9 | GO:0035934 | corticosterone secretion(GO:0035934) |
| 0.1 | 4.2 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.1 | 0.5 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
| 0.1 | 1.7 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 | 0.9 | GO:0031643 | positive regulation of myelination(GO:0031643) |
| 0.1 | 0.4 | GO:1905063 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) regulation of vascular smooth muscle cell differentiation(GO:1905063) negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
| 0.1 | 0.5 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 | 2.7 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 | 0.1 | GO:0051409 | response to nitrosative stress(GO:0051409) |
| 0.1 | 0.9 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 | 1.7 | GO:0036309 | protein localization to M-band(GO:0036309) |
| 0.1 | 1.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.1 | 1.6 | GO:0072554 | blood vessel lumenization(GO:0072554) |
| 0.1 | 1.0 | GO:0061709 | reticulophagy(GO:0061709) |
| 0.1 | 1.0 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.1 | 0.9 | GO:0015825 | L-serine transport(GO:0015825) |
| 0.1 | 0.6 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.1 | 1.0 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.1 | 0.3 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
| 0.1 | 1.8 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 | 0.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 | 2.9 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.1 | 3.3 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 | 6.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 | 0.5 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.1 | 0.4 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.1 | 0.4 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.1 | 0.6 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.1 | 0.6 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.1 | 3.0 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.1 | 0.1 | GO:0007070 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 0.1 | 2.4 | GO:0007567 | parturition(GO:0007567) |
| 0.1 | 0.4 | GO:0097698 | telomere maintenance via base-excision repair(GO:0097698) |
| 0.1 | 1.6 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
| 0.1 | 2.5 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
| 0.1 | 1.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.1 | 0.5 | GO:0050823 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 0.1 | 1.3 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.1 | 0.4 | GO:0003278 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) apoptotic process involved in heart morphogenesis(GO:0003278) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 0.1 | 0.6 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.1 | 0.5 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 | 1.2 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
| 0.1 | 0.4 | GO:0032364 | oxygen homeostasis(GO:0032364) |
| 0.1 | 1.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.1 | 0.6 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 0.1 | 0.4 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
| 0.1 | 0.5 | GO:0018277 | protein deamination(GO:0018277) |
| 0.1 | 0.6 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.1 | 0.1 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
| 0.1 | 4.9 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 | 0.8 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.1 | 2.6 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
| 0.1 | 1.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.1 | 0.4 | GO:0034776 | response to histamine(GO:0034776) |
| 0.1 | 2.1 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.1 | 1.0 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.1 | 3.3 | GO:0046710 | GDP metabolic process(GO:0046710) |
| 0.1 | 1.1 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.1 | 0.2 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.1 | 0.3 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.1 | 1.0 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 0.1 | 2.1 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
| 0.1 | 0.7 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
| 0.1 | 0.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 | 2.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.1 | 0.6 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.1 | 1.6 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.1 | 2.8 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.1 | 0.2 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 0.1 | 0.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.1 | 2.5 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 | 0.6 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.1 | 2.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.1 | 0.3 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
| 0.1 | 1.9 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.1 | 2.4 | GO:0051412 | response to corticosterone(GO:0051412) |
| 0.1 | 0.8 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.1 | 0.6 | GO:1901563 | response to camptothecin(GO:1901563) |
| 0.1 | 0.7 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.1 | 4.6 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.1 | 2.0 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
| 0.1 | 0.1 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
| 0.1 | 3.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 | 1.0 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
| 0.1 | 0.3 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.1 | 1.4 | GO:0032506 | cytokinetic process(GO:0032506) |
| 0.1 | 0.6 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.1 | 1.7 | GO:0060732 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.1 | 0.7 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 | 1.4 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.1 | 0.1 | GO:0048865 | stem cell fate commitment(GO:0048865) |
| 0.1 | 0.8 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
| 0.1 | 0.7 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
| 0.1 | 0.8 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
| 0.1 | 0.4 | GO:0006112 | energy reserve metabolic process(GO:0006112) |
| 0.1 | 0.3 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.1 | 2.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 | 0.3 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
| 0.1 | 0.8 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.1 | 0.2 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.1 | 1.2 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 | 0.8 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 | 1.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.1 | 0.3 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.1 | 4.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.1 | 0.4 | GO:0033058 | directional locomotion(GO:0033058) |
| 0.1 | 1.0 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 | 0.4 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.1 | 10.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.1 | 1.1 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.1 | 1.8 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.1 | 0.5 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.1 | 1.1 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
| 0.1 | 0.4 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.1 | 0.4 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.1 | 0.4 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 0.1 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
| 0.1 | 1.0 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.1 | 2.9 | GO:0046785 | microtubule polymerization(GO:0046785) |
| 0.1 | 0.8 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.1 | 0.9 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
| 0.1 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 0.1 | 0.8 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.1 | 1.9 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.1 | 0.3 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 | 4.6 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 | 0.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.1 | 0.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 | 0.7 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.1 | 1.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 0.1 | 1.1 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.1 | 0.9 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
| 0.1 | 0.3 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.1 | 7.8 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.1 | 0.1 | GO:0050893 | sensory processing(GO:0050893) |
| 0.1 | 1.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.1 | 1.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 0.1 | 0.3 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.1 | 1.9 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.1 | 0.9 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 | 0.3 | GO:0006147 | guanine catabolic process(GO:0006147) |
| 0.1 | 4.8 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.1 | 0.3 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
| 0.1 | 3.2 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.1 | 0.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 | 1.4 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
| 0.1 | 1.6 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
| 0.1 | 0.6 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 0.1 | 0.7 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.1 | 0.8 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 | 3.7 | GO:0060074 | synapse maturation(GO:0060074) |
| 0.1 | 1.6 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 | 0.3 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.1 | 0.9 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.1 | 0.4 | GO:0050992 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.1 | 1.0 | GO:0007413 | axonal fasciculation(GO:0007413) |
| 0.1 | 0.2 | GO:0070341 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 | 0.3 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
| 0.1 | 1.0 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 0.1 | 0.3 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.1 | 1.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.1 | 0.7 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.1 | 2.1 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.1 | 0.5 | GO:0010734 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.1 | 0.3 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 | 0.2 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
| 0.1 | 1.9 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.1 | 1.0 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 | 0.9 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.1 | 1.5 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.1 | 0.7 | GO:0051958 | methotrexate transport(GO:0051958) |
| 0.1 | 0.7 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.1 | 1.0 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.1 | 0.8 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.1 | 0.3 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.1 | 0.1 | GO:0061056 | sclerotome development(GO:0061056) |
| 0.1 | 3.4 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
| 0.1 | 1.9 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.1 | 0.7 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
| 0.1 | 0.4 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
| 0.1 | 0.8 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.1 | 0.2 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
| 0.1 | 0.3 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.1 | 0.4 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.1 | 0.3 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.1 | 0.7 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 | 0.3 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
| 0.1 | 0.6 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.1 | 0.3 | GO:0032053 | ciliary basal body organization(GO:0032053) |
| 0.1 | 0.9 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.1 | 0.4 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.1 | 0.8 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.1 | 0.5 | GO:0021826 | substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
| 0.1 | 3.7 | GO:0021762 | substantia nigra development(GO:0021762) |
| 0.1 | 1.0 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.1 | 0.2 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.1 | 0.3 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 | 1.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 | 0.7 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.1 | 0.9 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.1 | 0.4 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.1 | 3.3 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.1 | 0.8 | GO:1904377 | positive regulation of protein localization to cell periphery(GO:1904377) |
| 0.1 | 1.0 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.1 | 0.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.1 | 0.2 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 0.1 | 4.0 | GO:0050775 | positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.1 | 2.7 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.1 | 0.6 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.1 | 0.1 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
| 0.1 | 0.3 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 | 0.9 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
| 0.1 | 0.3 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.1 | 1.6 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
| 0.1 | 0.1 | GO:0072603 | interleukin-5 secretion(GO:0072603) regulation of interleukin-5 secretion(GO:2000662) |
| 0.1 | 3.7 | GO:1903391 | regulation of adherens junction organization(GO:1903391) |
| 0.1 | 0.3 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.1 | 0.3 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.1 | 0.7 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.1 | 1.4 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.1 | 0.4 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
| 0.1 | 2.8 | GO:0043297 | apical junction assembly(GO:0043297) |
| 0.1 | 0.2 | GO:0035809 | regulation of urine volume(GO:0035809) |
| 0.1 | 0.5 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.1 | 0.4 | GO:0006983 | ER overload response(GO:0006983) |
| 0.1 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.1 | 0.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 | 0.5 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 | 0.8 | GO:0015816 | glycine transport(GO:0015816) |
| 0.1 | 1.7 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.1 | 2.1 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) |
| 0.1 | 6.9 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.1 | 1.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.1 | 1.1 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
| 0.1 | 0.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 | 0.7 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
| 0.1 | 2.7 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 0.1 | 0.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.1 | 0.2 | GO:0045175 | basal protein localization(GO:0045175) |
| 0.1 | 0.5 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.1 | 0.6 | GO:0046689 | response to mercury ion(GO:0046689) |
| 0.1 | 0.8 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.1 | 0.1 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.1 | 1.2 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
| 0.1 | 2.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.1 | 0.3 | GO:0071280 | cellular response to copper ion(GO:0071280) |
| 0.1 | 0.2 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
| 0.1 | 0.2 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
| 0.1 | 0.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 | 0.5 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 | 0.2 | GO:0016556 | mRNA modification(GO:0016556) |
| 0.1 | 1.0 | GO:0042407 | cristae formation(GO:0042407) |
| 0.1 | 0.2 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.1 | 0.2 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.1 | 0.9 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
| 0.1 | 0.6 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
| 0.1 | 0.1 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
| 0.1 | 0.2 | GO:0019878 | lysine biosynthetic process(GO:0009085) lysine biosynthetic process via aminoadipic acid(GO:0019878) |
| 0.1 | 1.2 | GO:0075522 | IRES-dependent translational initiation(GO:0002192) IRES-dependent viral translational initiation(GO:0075522) |
| 0.1 | 7.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 | 0.2 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.1 | 0.2 | GO:0001975 | response to amphetamine(GO:0001975) |
| 0.1 | 1.0 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.1 | 1.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 | 3.0 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.1 | 0.1 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
| 0.1 | 0.4 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.1 | 0.2 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
| 0.1 | 0.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.1 | 0.4 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.1 | 0.3 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
| 0.1 | 0.4 | GO:0060384 | innervation(GO:0060384) |
| 0.1 | 0.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 | 0.7 | GO:0007097 | nuclear migration(GO:0007097) |
| 0.1 | 0.1 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
| 0.1 | 0.9 | GO:0070571 | negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
| 0.1 | 0.5 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.1 | 0.2 | GO:0014028 | notochord formation(GO:0014028) |
| 0.1 | 0.3 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.1 | 0.3 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.1 | 3.9 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.1 | 0.6 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.1 | 0.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.1 | 0.1 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
| 0.1 | 2.8 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
| 0.1 | 0.4 | GO:0008038 | neuron recognition(GO:0008038) |
| 0.1 | 0.8 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.1 | 0.7 | GO:0032801 | receptor catabolic process(GO:0032801) |
| 0.1 | 1.5 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.1 | 0.5 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.1 | 0.1 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
| 0.1 | 0.3 | GO:0022615 | protein to membrane docking(GO:0022615) |
| 0.1 | 0.4 | GO:0001765 | membrane raft assembly(GO:0001765) |
| 0.1 | 1.8 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
| 0.1 | 0.3 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.1 | 0.5 | GO:0048846 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
| 0.1 | 1.7 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.1 | 0.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 | 0.4 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 0.1 | 0.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.1 | 1.4 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 0.1 | 0.3 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.1 | 0.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
| 0.1 | 0.3 | GO:0051758 | homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
| 0.1 | 1.0 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.1 | 0.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.1 | 0.5 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.1 | 1.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
| 0.1 | 0.1 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.1 | 0.2 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
| 0.1 | 0.2 | GO:1904037 | positive regulation of epithelial cell apoptotic process(GO:1904037) |
| 0.1 | 0.9 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.1 | 0.5 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
| 0.1 | 2.7 | GO:0048675 | axon extension(GO:0048675) |
| 0.1 | 0.1 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.1 | 0.8 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.1 | 0.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.1 | 1.9 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.1 | 0.6 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
| 0.1 | 0.3 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.1 | 1.7 | GO:0006735 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.1 | 1.6 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 0.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.1 | 0.2 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
| 0.1 | 0.1 | GO:0003139 | secondary heart field specification(GO:0003139) |
| 0.1 | 0.2 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.1 | 0.5 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.1 | 0.4 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.1 | 1.5 | GO:0031102 | neuron projection regeneration(GO:0031102) |
| 0.1 | 0.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 | 0.2 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
| 0.1 | 0.2 | GO:2000351 | regulation of endothelial cell apoptotic process(GO:2000351) |
| 0.1 | 6.9 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.1 | 1.0 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.1 | 0.2 | GO:0070672 | response to interleukin-15(GO:0070672) |
| 0.1 | 0.1 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.1 | 0.4 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
| 0.1 | 0.5 | GO:2001222 | regulation of neuron migration(GO:2001222) |
| 0.1 | 0.2 | GO:1904106 | protein localization to microvillus(GO:1904106) |
| 0.1 | 0.6 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 | 5.6 | GO:0031032 | actomyosin structure organization(GO:0031032) |
| 0.1 | 0.2 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.1 | 0.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
| 0.1 | 1.0 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
| 0.1 | 0.1 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
| 0.1 | 0.1 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
| 0.1 | 0.3 | GO:0006551 | leucine metabolic process(GO:0006551) |
| 0.1 | 0.2 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.1 | 0.1 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.1 | 2.3 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.1 | 0.5 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.1 | 0.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.1 | 0.3 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 | 1.5 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 0.1 | 0.3 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.1 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) |
| 0.1 | 0.2 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
| 0.1 | 0.3 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.1 | 0.4 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 | 0.1 | GO:0050932 | regulation of pigment cell differentiation(GO:0050932) positive regulation of pigment cell differentiation(GO:0050942) |
| 0.1 | 0.3 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
| 0.1 | 0.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.1 | 0.6 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.1 | 0.5 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.1 | 4.4 | GO:0001764 | neuron migration(GO:0001764) |
| 0.1 | 0.3 | GO:0042311 | vasodilation(GO:0042311) |
| 0.1 | 0.2 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
| 0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.1 | 0.1 | GO:0061317 | canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) |
| 0.1 | 0.2 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.1 | 0.2 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.1 | 0.4 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 0.1 | 0.3 | GO:0010255 | hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.1 | 0.6 | GO:0003229 | ventricular cardiac muscle tissue development(GO:0003229) |
| 0.1 | 1.1 | GO:0010665 | regulation of cardiac muscle cell apoptotic process(GO:0010665) |
| 0.1 | 1.1 | GO:0051602 | response to electrical stimulus(GO:0051602) |
| 0.1 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.1 | 0.4 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.1 | 0.8 | GO:0015886 | heme transport(GO:0015886) |
| 0.1 | 6.6 | GO:0070268 | cornification(GO:0070268) |
| 0.1 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.1 | 0.2 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
| 0.1 | 3.1 | GO:0048278 | vesicle docking(GO:0048278) |
| 0.1 | 0.1 | GO:0021764 | amygdala development(GO:0021764) |
| 0.0 | 0.1 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 0.0 | 0.0 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.0 | 0.8 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.0 | 0.5 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.0 | 1.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.0 | 0.1 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
| 0.0 | 0.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 | 1.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.0 | 0.5 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
| 0.0 | 0.0 | GO:0060995 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.0 | 0.0 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.0 | 2.0 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
| 0.0 | 1.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.0 | 0.4 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.0 | 0.6 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 | 0.1 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
| 0.0 | 0.2 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.0 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 | 0.7 | GO:0043114 | regulation of vascular permeability(GO:0043114) |
| 0.0 | 0.2 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
| 0.0 | 0.3 | GO:0019075 | virus maturation(GO:0019075) |
| 0.0 | 0.2 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.0 | 1.7 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.0 | 0.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 | 0.2 | GO:2000010 | cardiac muscle tissue regeneration(GO:0061026) positive regulation of protein localization to cell surface(GO:2000010) |
| 0.0 | 0.2 | GO:0045209 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.0 | 0.1 | GO:0035048 | splicing factor protein import into nucleus(GO:0035048) |
| 0.0 | 0.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.0 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.0 | 0.1 | GO:0000964 | mitochondrial RNA 5'-end processing(GO:0000964) |
| 0.0 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.0 | 0.0 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.0 | 0.2 | GO:0010607 | negative regulation of cytoplasmic mRNA processing body assembly(GO:0010607) |
| 0.0 | 1.3 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
| 0.0 | 0.2 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.0 | 2.0 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.0 | 0.1 | GO:0010159 | specification of organ position(GO:0010159) |
| 0.0 | 0.5 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
| 0.0 | 0.3 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.0 | 0.5 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
| 0.0 | 0.6 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) |
| 0.0 | 1.2 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.0 | 0.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.0 | 0.2 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) |
| 0.0 | 0.1 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
| 0.0 | 0.9 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
| 0.0 | 0.0 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 0.0 | 0.3 | GO:0010934 | macrophage cytokine production(GO:0010934) regulation of macrophage cytokine production(GO:0010935) |
| 0.0 | 0.4 | GO:0009650 | UV protection(GO:0009650) |
| 0.0 | 0.2 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
| 0.0 | 2.6 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
| 0.0 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.0 | 0.2 | GO:0051036 | regulation of endosome size(GO:0051036) |
| 0.0 | 0.1 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.0 | 0.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.0 | 0.7 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.0 | 0.2 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.0 | 0.4 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.0 | 0.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.0 | 0.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 | 0.2 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.0 | 0.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.0 | 0.3 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.0 | 1.6 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
| 0.0 | 0.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.0 | 0.7 | GO:0044088 | regulation of vacuole organization(GO:0044088) |
| 0.0 | 0.3 | GO:0015866 | ADP transport(GO:0015866) |
| 0.0 | 0.3 | GO:0001946 | lymphangiogenesis(GO:0001946) |
| 0.0 | 0.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.0 | 0.2 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.0 | 9.4 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
| 0.0 | 0.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.0 | 0.6 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.0 | 0.3 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
| 0.0 | 0.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.0 | 0.5 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.0 | 0.1 | GO:0033306 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 0.0 | 0.4 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.0 | 0.9 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.0 | 0.6 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.0 | 0.1 | GO:0071697 | ectodermal placode formation(GO:0060788) ectodermal placode development(GO:0071696) ectodermal placode morphogenesis(GO:0071697) |
| 0.0 | 0.1 | GO:0072237 | isoleucine catabolic process(GO:0006550) proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) metanephric proximal tubule development(GO:0072237) |
| 0.0 | 1.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.0 | 0.1 | GO:0045345 | positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.0 | 0.1 | GO:0070078 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine(GO:0018395) histone arginine demethylation(GO:0070077) histone H3-R2 demethylation(GO:0070078) histone H4-R3 demethylation(GO:0070079) |
| 0.0 | 0.1 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
| 0.0 | 0.0 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) |
| 0.0 | 0.2 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
| 0.0 | 0.2 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.0 | 0.1 | GO:0060592 | mammary gland formation(GO:0060592) |
| 0.0 | 0.1 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
| 0.0 | 0.0 | GO:0070243 | regulation of thymocyte apoptotic process(GO:0070243) |
| 0.0 | 0.8 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.0 | 0.1 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.0 | 0.1 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
| 0.0 | 0.0 | GO:0071609 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) chemokine (C-C motif) ligand 5 production(GO:0071609) response to host(GO:0075136) |
| 0.0 | 0.5 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
| 0.0 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.0 | 0.1 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
| 0.0 | 0.1 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.0 | 0.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
| 0.0 | 0.5 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
| 0.0 | 0.5 | GO:0097576 | vacuole fusion(GO:0097576) |
| 0.0 | 0.1 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
| 0.0 | 0.3 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.0 | 0.6 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.0 | 0.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.0 | 1.3 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
| 0.0 | 1.2 | GO:0032760 | positive regulation of tumor necrosis factor production(GO:0032760) |
| 0.0 | 0.4 | GO:0021885 | forebrain cell migration(GO:0021885) |
| 0.0 | 0.2 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
| 0.0 | 0.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 | 0.5 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.0 | 0.1 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.0 | 0.2 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.0 | 0.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.0 | 0.0 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
| 0.0 | 0.1 | GO:0009886 | post-embryonic morphogenesis(GO:0009886) |
| 0.0 | 0.4 | GO:0015074 | DNA integration(GO:0015074) |
| 0.0 | 0.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.0 | 0.5 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.0 | 0.1 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.0 | 0.5 | GO:0019076 | viral release from host cell(GO:0019076) |
| 0.0 | 0.1 | GO:0009305 | protein biotinylation(GO:0009305) histone biotinylation(GO:0071110) |
| 0.0 | 0.1 | GO:2000503 | regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.0 | 0.1 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 0.0 | 0.1 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.0 | 0.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.0 | 0.1 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.0 | 0.2 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.0 | 0.6 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
| 0.0 | 0.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
| 0.0 | 0.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.0 | 1.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.0 | 0.4 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
| 0.0 | 0.5 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
| 0.0 | 1.7 | GO:0007602 | phototransduction(GO:0007602) |
| 0.0 | 0.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.0 | 0.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
| 0.0 | 0.1 | GO:0033341 | regulation of collagen binding(GO:0033341) |
| 0.0 | 0.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.0 | 0.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.0 | 0.2 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.0 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.0 | 0.2 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.0 | 0.1 | GO:0015884 | folic acid transport(GO:0015884) |
| 0.0 | 3.3 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
| 0.0 | 0.3 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
| 0.0 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.0 | 0.5 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.0 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.0 | 0.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.0 | 0.4 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.0 | 0.1 | GO:1902226 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
| 0.0 | 0.2 | GO:0014003 | oligodendrocyte development(GO:0014003) |
| 0.0 | 0.1 | GO:0042026 | protein refolding(GO:0042026) |
| 0.0 | 0.1 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.0 | 2.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 | 0.0 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
| 0.0 | 0.5 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.0 | 0.4 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.0 | 0.5 | GO:2000181 | negative regulation of blood vessel morphogenesis(GO:2000181) |
| 0.0 | 4.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 | 0.3 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.0 | 0.3 | GO:0097186 | amelogenesis(GO:0097186) |
| 0.0 | 0.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.0 | 0.2 | GO:0044211 | CTP salvage(GO:0044211) |
| 0.0 | 0.1 | GO:2001311 | lysobisphosphatidic acid metabolic process(GO:2001311) |
| 0.0 | 0.1 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
| 0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.0 | 0.2 | GO:0090148 | membrane fission(GO:0090148) |
| 0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.0 | 0.1 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.0 | 0.2 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.0 | 0.1 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
| 0.0 | 0.4 | GO:0045008 | depyrimidination(GO:0045008) |
| 0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 | 0.1 | GO:0003360 | brainstem development(GO:0003360) |
| 0.0 | 0.2 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.0 | 0.4 | GO:2001057 | reactive nitrogen species metabolic process(GO:2001057) |
| 0.0 | 0.3 | GO:0071806 | protein transmembrane transport(GO:0071806) |
| 0.0 | 0.5 | GO:0060004 | reflex(GO:0060004) |
| 0.0 | 0.9 | GO:0010634 | positive regulation of epithelial cell migration(GO:0010634) |
| 0.0 | 0.6 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.0 | 0.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.0 | 0.6 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.0 | 0.4 | GO:0060996 | dendritic spine development(GO:0060996) |
| 0.0 | 1.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 | 0.6 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 0.0 | 0.1 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.0 | 0.0 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.0 | 0.1 | GO:0042428 | serotonin metabolic process(GO:0042428) |
| 0.0 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
| 0.0 | 0.2 | GO:0016075 | rRNA catabolic process(GO:0016075) |
| 0.0 | 0.6 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.0 | 0.1 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
| 0.0 | 0.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.0 | 0.0 | GO:0051546 | keratinocyte migration(GO:0051546) |
| 0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.0 | 0.1 | GO:0045007 | depurination(GO:0045007) |
| 0.0 | 0.1 | GO:0009136 | purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.0 | 0.1 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.0 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 | 0.1 | GO:1903565 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.0 | 0.1 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
| 0.0 | 0.5 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
| 0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.0 | 0.1 | GO:0061311 | cell surface receptor signaling pathway involved in heart development(GO:0061311) |
| 0.0 | 0.1 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.0 | 0.0 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.0 | 0.1 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
| 0.0 | 0.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.0 | 0.1 | GO:0006404 | RNA import into nucleus(GO:0006404) |
| 0.0 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.0 | 0.2 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
| 0.0 | 0.0 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.0 | 0.0 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.0 | 0.1 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
| 0.0 | 0.3 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 0.0 | 0.1 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.0 | 0.7 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.0 | 0.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.0 | 0.0 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.0 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.0 | 0.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.0 | 0.0 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 4.3 | GO:0060987 | lipid tube(GO:0060987) |
| 1.4 | 4.1 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 1.1 | 6.7 | GO:0014802 | terminal cisterna(GO:0014802) |
| 1.1 | 10.0 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 0.9 | 3.6 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 0.9 | 4.3 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 0.9 | 10.2 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 0.8 | 4.2 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.8 | 6.5 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.8 | 2.4 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
| 0.8 | 0.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.8 | 3.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.7 | 3.0 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 0.7 | 5.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.7 | 12.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.7 | 5.1 | GO:0097513 | myosin II filament(GO:0097513) |
| 0.7 | 8.6 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.6 | 4.5 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.6 | 2.6 | GO:0097637 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
| 0.6 | 3.8 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.6 | 3.2 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.6 | 10.6 | GO:0005861 | troponin complex(GO:0005861) |
| 0.6 | 3.0 | GO:0016938 | kinesin I complex(GO:0016938) |
| 0.6 | 1.8 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.6 | 0.6 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.5 | 2.2 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.5 | 3.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.5 | 1.5 | GO:1990742 | microvesicle(GO:1990742) |
| 0.5 | 3.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.5 | 1.5 | GO:0071665 | gamma-catenin-TCF7L2 complex(GO:0071665) |
| 0.5 | 2.0 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.5 | 11.5 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.5 | 20.7 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.5 | 0.5 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.5 | 0.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.5 | 0.9 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
| 0.4 | 8.9 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.4 | 3.5 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.4 | 2.6 | GO:0044308 | axonal spine(GO:0044308) |
| 0.4 | 1.3 | GO:0098844 | postsynaptic endocytic zone membrane(GO:0098844) |
| 0.4 | 3.0 | GO:0044301 | climbing fiber(GO:0044301) |
| 0.4 | 8.7 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
| 0.4 | 2.0 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.4 | 7.5 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.4 | 1.2 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
| 0.4 | 4.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.4 | 1.9 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.4 | 4.2 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 0.4 | 3.0 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.4 | 0.4 | GO:0097441 | basilar dendrite(GO:0097441) |
| 0.4 | 6.8 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.4 | 4.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.4 | 1.1 | GO:0044753 | amphisome(GO:0044753) |
| 0.4 | 1.1 | GO:1990913 | sperm head plasma membrane(GO:1990913) ooplasm(GO:1990917) |
| 0.4 | 0.4 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.4 | 1.1 | GO:0099569 | cytoskeleton of presynaptic active zone(GO:0048788) presynaptic active zone cytoplasmic component(GO:0098831) presynaptic cytoskeleton(GO:0099569) |
| 0.4 | 1.4 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 0.4 | 7.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.3 | 0.3 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.3 | 2.4 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.3 | 0.7 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.3 | 3.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.3 | 9.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.3 | 2.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.3 | 5.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.3 | 11.9 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.3 | 2.5 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.3 | 2.5 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
| 0.3 | 1.9 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.3 | 0.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.3 | 1.6 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.3 | 1.2 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
| 0.3 | 5.2 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.3 | 0.3 | GO:0044393 | microspike(GO:0044393) |
| 0.3 | 1.2 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
| 0.3 | 0.9 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.3 | 1.8 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.3 | 2.1 | GO:0071942 | XPC complex(GO:0071942) |
| 0.3 | 0.6 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.3 | 1.5 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.3 | 2.6 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 0.3 | 8.6 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.3 | 6.0 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.3 | 1.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
| 0.3 | 1.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.3 | 0.3 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
| 0.3 | 2.5 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.3 | 1.4 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.3 | 1.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.3 | 28.8 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.3 | 1.4 | GO:0002133 | polycystin complex(GO:0002133) |
| 0.3 | 5.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.3 | 1.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.3 | 11.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.3 | 1.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.3 | 0.8 | GO:0055087 | Ski complex(GO:0055087) |
| 0.3 | 1.6 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.3 | 0.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.3 | 1.3 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.3 | 31.6 | GO:0016528 | sarcoplasm(GO:0016528) |
| 0.3 | 2.0 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.3 | 4.3 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.3 | 1.5 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.3 | 1.3 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.3 | 4.3 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.3 | 2.5 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.2 | 2.0 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.2 | 1.2 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 0.2 | 2.2 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.2 | 3.4 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.2 | 1.0 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
| 0.2 | 1.0 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.2 | 3.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.2 | 1.0 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.2 | 1.7 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
| 0.2 | 1.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.2 | 4.0 | GO:0043219 | lateral loop(GO:0043219) |
| 0.2 | 3.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.2 | 2.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.2 | 0.7 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 0.2 | 3.0 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.2 | 2.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.2 | 1.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.2 | 1.1 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.2 | 1.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.2 | 5.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.2 | 9.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.2 | 3.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
| 0.2 | 11.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.2 | 6.3 | GO:0046930 | pore complex(GO:0046930) |
| 0.2 | 8.6 | GO:0030057 | desmosome(GO:0030057) |
| 0.2 | 1.1 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.2 | 1.3 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.2 | 1.7 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.2 | 0.6 | GO:0070685 | macropinocytic cup(GO:0070685) |
| 0.2 | 2.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.2 | 7.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.2 | 1.0 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.2 | 1.4 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.2 | 4.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.2 | 23.9 | GO:0005776 | autophagosome(GO:0005776) |
| 0.2 | 3.2 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.2 | 6.2 | GO:0043034 | costamere(GO:0043034) |
| 0.2 | 1.8 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.2 | 6.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.2 | 1.4 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.2 | 2.3 | GO:0005883 | neurofilament(GO:0005883) |
| 0.2 | 22.9 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.2 | 1.4 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.2 | 1.0 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.2 | 8.3 | GO:0071437 | invadopodium(GO:0071437) |
| 0.2 | 9.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.2 | 1.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.2 | 1.5 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.2 | 3.6 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.2 | 1.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.2 | 0.7 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.2 | 1.3 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.2 | 2.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.2 | 0.5 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.2 | 3.2 | GO:0045180 | basal cortex(GO:0045180) |
| 0.2 | 5.2 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.2 | 0.5 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.2 | 3.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.2 | 2.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.2 | 0.9 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
| 0.2 | 1.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.2 | 1.9 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.2 | 0.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.2 | 3.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.2 | 7.0 | GO:0031430 | M band(GO:0031430) |
| 0.2 | 1.8 | GO:0016342 | catenin complex(GO:0016342) |
| 0.2 | 0.7 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
| 0.2 | 0.3 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 0.2 | 6.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.2 | 1.9 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.2 | 1.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.2 | 0.8 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.2 | 1.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.2 | 1.0 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.2 | 2.8 | GO:0034709 | methylosome(GO:0034709) |
| 0.2 | 0.8 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.2 | 1.3 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
| 0.2 | 3.5 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.2 | 0.8 | GO:0001651 | dense fibrillar component(GO:0001651) |
| 0.2 | 7.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.2 | 2.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.2 | 1.3 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.2 | 2.7 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.2 | 1.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.2 | 0.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.2 | 2.5 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.2 | 2.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.2 | 0.5 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.2 | 2.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.2 | 2.0 | GO:0001939 | female pronucleus(GO:0001939) |
| 0.2 | 1.5 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 0.1 | 0.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.1 | 0.9 | GO:0031985 | Golgi cisterna(GO:0031985) |
| 0.1 | 17.7 | GO:0042641 | actomyosin(GO:0042641) |
| 0.1 | 4.6 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.1 | 0.9 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.1 | 0.3 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.1 | 0.9 | GO:0045240 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) dihydrolipoyl dehydrogenase complex(GO:0045240) |
| 0.1 | 12.7 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 0.1 | 1.2 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.1 | 2.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.1 | 3.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.1 | 7.5 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 0.1 | 1.8 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.1 | 4.3 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 5.8 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
| 0.1 | 2.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.1 | 1.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.1 | 1.0 | GO:0044448 | cell cortex part(GO:0044448) |
| 0.1 | 1.0 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.1 | 0.5 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.1 | 0.4 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.1 | 1.3 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.1 | 0.4 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.1 | 0.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.1 | 1.7 | GO:0008091 | spectrin(GO:0008091) |
| 0.1 | 0.8 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.1 | 1.0 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.1 | 0.5 | GO:0071556 | integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
| 0.1 | 0.7 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.1 | 2.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 0.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.1 | 1.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.1 | 14.2 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.1 | 0.8 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.1 | 3.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.1 | 2.6 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.1 | 9.9 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.1 | 1.5 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.1 | 1.3 | GO:0005638 | lamin filament(GO:0005638) |
| 0.1 | 2.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.1 | 8.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.1 | 3.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.1 | 2.9 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.1 | 0.5 | GO:0036338 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
| 0.1 | 0.8 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.1 | 0.2 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.1 | 1.2 | GO:0043218 | compact myelin(GO:0043218) |
| 0.1 | 0.3 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.1 | 0.4 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 0.1 | 0.3 | GO:1990393 | 3M complex(GO:1990393) |
| 0.1 | 8.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.1 | 0.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.1 | 9.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.1 | 22.4 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.1 | 0.5 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.1 | 2.6 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.1 | 1.6 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.1 | 0.4 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.1 | 0.3 | GO:0030849 | autosome(GO:0030849) |
| 0.1 | 1.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.1 | 1.3 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.1 | 2.0 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 1.0 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.1 | 0.3 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.1 | 0.5 | GO:0072534 | perineuronal net(GO:0072534) |
| 0.1 | 3.5 | GO:0002102 | podosome(GO:0002102) |
| 0.1 | 1.1 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.1 | 0.7 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.1 | 2.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 0.9 | GO:0032590 | dendrite membrane(GO:0032590) |
| 0.1 | 1.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.1 | 1.1 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.1 | 0.4 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.1 | 0.1 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 0.1 | 0.3 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.1 | 0.4 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.1 | 2.1 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.1 | 18.0 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.1 | 0.8 | GO:0030478 | actin cap(GO:0030478) |
| 0.1 | 2.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.1 | 0.7 | GO:0031417 | NatC complex(GO:0031417) |
| 0.1 | 0.6 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.1 | 0.3 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.1 | 5.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.1 | 1.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.1 | 0.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.1 | 2.1 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 1.4 | GO:0034464 | BBSome(GO:0034464) |
| 0.1 | 1.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.1 | 1.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.1 | 1.3 | GO:0030904 | retromer complex(GO:0030904) |
| 0.1 | 1.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.1 | 15.1 | GO:0043292 | contractile fiber(GO:0043292) |
| 0.1 | 3.4 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
| 0.1 | 0.4 | GO:0043196 | varicosity(GO:0043196) |
| 0.1 | 22.5 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
| 0.1 | 21.7 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.1 | 0.2 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.1 | 0.8 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.1 | 0.2 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
| 0.1 | 6.6 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.1 | 29.9 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.1 | 2.1 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
| 0.1 | 1.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.1 | 1.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.1 | 0.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.1 | 0.6 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.1 | 1.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.1 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.1 | 6.1 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 0.9 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.1 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.1 | 0.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.1 | 1.7 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.1 | 0.5 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.1 | 1.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.1 | 0.2 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.1 | 0.2 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 0.1 | 0.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.1 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 0.1 | 4.1 | GO:0098793 | presynapse(GO:0098793) |
| 0.1 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.1 | 1.3 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.1 | 6.1 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.1 | 0.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.1 | 0.7 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.1 | 4.4 | GO:0005901 | caveola(GO:0005901) |
| 0.1 | 9.9 | GO:0005770 | late endosome(GO:0005770) |
| 0.1 | 0.7 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.1 | 1.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 0.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.1 | 0.5 | GO:0032021 | NELF complex(GO:0032021) |
| 0.1 | 1.4 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.1 | 0.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.1 | 0.7 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
| 0.1 | 0.1 | GO:0032982 | myosin filament(GO:0032982) |
| 0.1 | 3.9 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.1 | 0.4 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.1 | 8.3 | GO:0030424 | axon(GO:0030424) |
| 0.1 | 24.7 | GO:0043025 | neuronal cell body(GO:0043025) |
| 0.1 | 5.2 | GO:0030658 | transport vesicle membrane(GO:0030658) |
| 0.1 | 0.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.1 | 0.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.1 | 1.5 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.1 | 4.9 | GO:0036477 | somatodendritic compartment(GO:0036477) |
| 0.1 | 3.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.1 | 0.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.1 | 0.5 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.1 | 1.2 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.1 | 0.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.1 | 4.2 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.1 | 1.5 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 0.3 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.1 | 0.6 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.1 | 0.6 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
| 0.1 | 2.0 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.1 | 5.0 | GO:0030426 | growth cone(GO:0030426) |
| 0.1 | 2.4 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.1 | 0.2 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) USH2 complex(GO:1990696) |
| 0.1 | 0.3 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.1 | 0.3 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.1 | 1.8 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.1 | 4.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 0.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.1 | 0.4 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.0 | 0.3 | GO:0016011 | dystroglycan complex(GO:0016011) |
| 0.0 | 2.2 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
| 0.0 | 0.6 | GO:0008305 | integrin complex(GO:0008305) |
| 0.0 | 0.1 | GO:0009346 | citrate lyase complex(GO:0009346) |
| 0.0 | 2.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.0 | 0.7 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
| 0.0 | 6.9 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.0 | 0.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.0 | 1.0 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.0 | 0.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.0 | 6.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 2.3 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 0.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.0 | 0.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.0 | 0.2 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
| 0.0 | 0.1 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.0 | 0.5 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.0 | 0.4 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.0 | 0.7 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.0 | 0.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.0 | 0.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.0 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
| 0.0 | 0.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.0 | 4.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.0 | 0.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.0 | 0.2 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.0 | 7.6 | GO:0098857 | membrane microdomain(GO:0098857) |
| 0.0 | 4.8 | GO:0070161 | anchoring junction(GO:0070161) |
| 0.0 | 18.4 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.0 | 0.3 | GO:0016589 | NURF complex(GO:0016589) |
| 0.0 | 0.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.0 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.0 | 0.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.0 | 0.8 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.0 | 3.9 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.0 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.0 | 0.2 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.0 | 0.2 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.0 | 0.2 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.0 | 0.3 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.0 | 19.6 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.0 | 0.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.0 | 3.2 | GO:0005604 | basement membrane(GO:0005604) |
| 0.0 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.0 | 0.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.0 | 0.0 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.0 | 0.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.0 | 23.2 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.0 | 0.3 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.0 | 0.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.0 | 0.1 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 0.0 | 13.8 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.0 | 0.1 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.0 | 0.1 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.0 | 0.3 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.0 | 0.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.0 | 1.6 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.0 | 0.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.0 | 0.0 | GO:0032059 | bleb(GO:0032059) |
| 0.0 | 1.3 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
| 0.0 | 4.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 61.0 | GO:0043230 | extracellular organelle(GO:0043230) |
| 0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.0 | 0.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.0 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.0 | 0.2 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.0 | 0.2 | GO:0090576 | transcription factor TFIIIC complex(GO:0000127) RNA polymerase III transcription factor complex(GO:0090576) |
| 0.0 | 0.2 | GO:0030662 | coated vesicle membrane(GO:0030662) |
| 0.0 | 0.3 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.0 | 0.5 | GO:0042383 | sarcolemma(GO:0042383) |
| 0.0 | 0.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.0 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
| 0.0 | 0.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.0 | 0.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.0 | 0.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.0 | 0.0 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.0 | 0.1 | GO:0070469 | respiratory chain(GO:0070469) |
| 0.0 | 19.0 | GO:0005739 | mitochondrion(GO:0005739) |
| 0.0 | 0.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 0.3 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.0 | 0.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.0 | 1.1 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.0 | 0.1 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
| 0.0 | 0.1 | GO:0031984 | organelle subcompartment(GO:0031984) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 12.2 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 1.5 | 4.5 | GO:0031775 | lutropin-choriogonadotropic hormone receptor binding(GO:0031775) calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential(GO:0086039) |
| 1.3 | 6.7 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 1.2 | 5.0 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 1.2 | 7.3 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
| 1.1 | 3.3 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
| 1.1 | 3.3 | GO:0038100 | nodal binding(GO:0038100) |
| 1.0 | 3.9 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
| 1.0 | 3.8 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
| 0.9 | 2.7 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
| 0.9 | 2.7 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
| 0.9 | 2.7 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 0.9 | 2.7 | GO:0004108 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
| 0.9 | 4.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.9 | 11.4 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.8 | 5.9 | GO:0031705 | bombesin receptor binding(GO:0031705) |
| 0.8 | 14.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.8 | 4.1 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 0.8 | 2.5 | GO:0031737 | CX3C chemokine receptor binding(GO:0031737) |
| 0.8 | 13.8 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.8 | 6.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.8 | 0.8 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 0.8 | 2.3 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
| 0.8 | 3.0 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.8 | 3.8 | GO:1904408 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 0.7 | 2.9 | GO:0030395 | lactose binding(GO:0030395) |
| 0.7 | 4.3 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 0.7 | 2.8 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
| 0.7 | 4.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.7 | 2.7 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.7 | 2.7 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.7 | 7.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.7 | 2.0 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.7 | 3.3 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.6 | 1.9 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
| 0.6 | 3.8 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.6 | 1.9 | GO:0008434 | calcitriol receptor activity(GO:0008434) lithocholic acid receptor activity(GO:0038186) calcitriol binding(GO:1902098) lithocholic acid binding(GO:1902121) |
| 0.6 | 1.9 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
| 0.6 | 5.7 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.6 | 2.5 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
| 0.6 | 1.9 | GO:0047315 | kynurenine-glyoxylate transaminase activity(GO:0047315) |
| 0.6 | 3.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.6 | 5.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.6 | 1.2 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
| 0.6 | 1.7 | GO:0031696 | alpha-2C adrenergic receptor binding(GO:0031696) |
| 0.6 | 6.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.6 | 2.8 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 0.6 | 9.9 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.5 | 1.6 | GO:2001069 | glycogen binding(GO:2001069) |
| 0.5 | 2.2 | GO:0004513 | neolactotetraosylceramide alpha-2,3-sialyltransferase activity(GO:0004513) lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
| 0.5 | 2.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.5 | 7.0 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.5 | 2.1 | GO:0004360 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity(GO:0004360) |
| 0.5 | 3.7 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.5 | 3.1 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.5 | 5.1 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.5 | 2.0 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 0.5 | 7.1 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.5 | 1.5 | GO:0004314 | [acyl-carrier-protein] S-malonyltransferase activity(GO:0004314) S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
| 0.5 | 2.5 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.5 | 1.5 | GO:0032093 | SAM domain binding(GO:0032093) |
| 0.5 | 4.5 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.5 | 3.0 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.5 | 6.4 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.5 | 15.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.5 | 1.5 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
| 0.5 | 1.0 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.5 | 3.8 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.5 | 1.9 | GO:0032427 | GBD domain binding(GO:0032427) |
| 0.5 | 6.0 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.5 | 1.4 | GO:0005135 | interleukin-3 receptor binding(GO:0005135) |
| 0.5 | 5.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.4 | 1.3 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
| 0.4 | 2.6 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.4 | 7.9 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.4 | 0.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
| 0.4 | 3.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.4 | 0.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.4 | 1.3 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
| 0.4 | 4.7 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.4 | 1.7 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.4 | 4.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.4 | 3.4 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.4 | 2.1 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.4 | 2.5 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.4 | 1.6 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.4 | 3.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.4 | 0.8 | GO:0051380 | norepinephrine binding(GO:0051380) |
| 0.4 | 4.4 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.4 | 2.4 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
| 0.4 | 1.6 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.4 | 2.0 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.4 | 2.8 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.4 | 2.0 | GO:0000406 | double-strand/single-strand DNA junction binding(GO:0000406) dinucleotide repeat insertion binding(GO:0032181) |
| 0.4 | 0.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.4 | 1.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.4 | 3.5 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.4 | 1.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.4 | 1.9 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
| 0.4 | 0.8 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 0.4 | 1.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.4 | 3.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.4 | 1.8 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
| 0.4 | 2.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.4 | 4.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.4 | 1.1 | GO:0046715 | borate transmembrane transporter activity(GO:0046715) |
| 0.4 | 4.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.4 | 0.7 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
| 0.4 | 5.4 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.4 | 2.5 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.4 | 1.4 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 0.4 | 1.1 | GO:0046970 | NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
| 0.4 | 1.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.4 | 0.7 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 0.4 | 2.8 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.4 | 3.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.4 | 1.1 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 0.4 | 1.1 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
| 0.4 | 11.0 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.4 | 1.8 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 0.4 | 5.3 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.4 | 1.1 | GO:0047661 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.4 | 1.8 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.3 | 1.4 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 0.3 | 1.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.3 | 1.0 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
| 0.3 | 1.4 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
| 0.3 | 1.4 | GO:0070012 | oligopeptidase activity(GO:0070012) |
| 0.3 | 2.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.3 | 12.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.3 | 2.0 | GO:0003983 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 0.3 | 1.0 | GO:0036332 | VEGF-A-activated receptor activity(GO:0036326) VEGF-B-activated receptor activity(GO:0036327) placental growth factor-activated receptor activity(GO:0036332) |
| 0.3 | 1.0 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
| 0.3 | 11.2 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.3 | 1.0 | GO:0070364 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
| 0.3 | 15.1 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.3 | 11.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.3 | 5.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.3 | 1.0 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 0.3 | 1.3 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.3 | 3.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.3 | 1.0 | GO:0016497 | substance K receptor activity(GO:0016497) |
| 0.3 | 1.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.3 | 4.2 | GO:0015288 | porin activity(GO:0015288) |
| 0.3 | 1.6 | GO:0004802 | transketolase activity(GO:0004802) |
| 0.3 | 3.2 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.3 | 6.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 0.3 | 1.0 | GO:0080023 | 3R-hydroxyacyl-CoA dehydratase activity(GO:0080023) |
| 0.3 | 6.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.3 | 3.2 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.3 | 4.1 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.3 | 7.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.3 | 0.9 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.3 | 1.6 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 0.3 | 1.6 | GO:1903135 | cupric ion binding(GO:1903135) |
| 0.3 | 1.5 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.3 | 3.1 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.3 | 1.2 | GO:0004733 | pyridoxamine-phosphate oxidase activity(GO:0004733) |
| 0.3 | 1.2 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.3 | 2.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.3 | 5.4 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
| 0.3 | 5.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.3 | 1.2 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.3 | 0.6 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 0.3 | 1.8 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.3 | 2.4 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.3 | 2.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.3 | 1.8 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.3 | 5.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.3 | 6.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.3 | 1.5 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 0.3 | 2.3 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 0.3 | 0.6 | GO:0004096 | catalase activity(GO:0004096) |
| 0.3 | 2.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.3 | 8.3 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.3 | 4.3 | GO:0046790 | virion binding(GO:0046790) |
| 0.3 | 15.3 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.3 | 2.8 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.3 | 0.8 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
| 0.3 | 5.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.3 | 2.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.3 | 5.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.3 | 2.5 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.3 | 5.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.3 | 1.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.3 | 2.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.3 | 12.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.3 | 0.8 | GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
| 0.3 | 0.8 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
| 0.3 | 0.8 | GO:0061598 | nitrate reductase activity(GO:0008940) molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
| 0.3 | 1.1 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.3 | 0.8 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.3 | 1.6 | GO:0051870 | methotrexate binding(GO:0051870) |
| 0.3 | 1.6 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.3 | 4.5 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.3 | 1.3 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
| 0.3 | 0.8 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
| 0.3 | 1.0 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.3 | 3.6 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.3 | 1.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.3 | 1.3 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.3 | 0.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.3 | 4.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.3 | 2.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.3 | 2.0 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.3 | 2.3 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
| 0.3 | 3.3 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
| 0.3 | 1.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.3 | 0.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.2 | 0.7 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.2 | 4.0 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
| 0.2 | 1.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.2 | 2.0 | GO:0034618 | arginine binding(GO:0034618) |
| 0.2 | 0.5 | GO:0038064 | collagen receptor activity(GO:0038064) |
| 0.2 | 2.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.2 | 0.5 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.2 | 6.8 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.2 | 0.7 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.2 | 2.2 | GO:0043426 | MRF binding(GO:0043426) |
| 0.2 | 1.0 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.2 | 0.7 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
| 0.2 | 1.4 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.2 | 1.2 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.2 | 4.0 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.2 | 1.9 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.2 | 1.9 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.2 | 2.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.2 | 2.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.2 | 0.7 | GO:0005369 | taurine transmembrane transporter activity(GO:0005368) taurine:sodium symporter activity(GO:0005369) |
| 0.2 | 2.3 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
| 0.2 | 2.8 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.2 | 1.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.2 | 2.7 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.2 | 1.6 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.2 | 4.9 | GO:0019841 | retinol binding(GO:0019841) |
| 0.2 | 4.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.2 | 0.9 | GO:0070224 | sulfide:quinone oxidoreductase activity(GO:0070224) |
| 0.2 | 0.9 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.2 | 0.4 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
| 0.2 | 1.1 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.2 | 3.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.2 | 2.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.2 | 19.1 | GO:0019003 | GDP binding(GO:0019003) |
| 0.2 | 0.4 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
| 0.2 | 0.2 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.2 | 0.6 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.2 | 3.2 | GO:0008430 | selenium binding(GO:0008430) |
| 0.2 | 1.5 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.2 | 1.1 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 0.2 | 1.1 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.2 | 1.7 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 0.2 | 1.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.2 | 1.0 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.2 | 1.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.2 | 0.8 | GO:0004001 | adenosine kinase activity(GO:0004001) |
| 0.2 | 10.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.2 | 0.6 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.2 | 1.9 | GO:0070728 | leucine binding(GO:0070728) |
| 0.2 | 13.8 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.2 | 1.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.2 | 0.8 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 0.2 | 0.8 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.2 | 3.9 | GO:0005536 | glucose binding(GO:0005536) |
| 0.2 | 1.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.2 | 0.8 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.2 | 1.2 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.2 | 7.3 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.2 | 5.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.2 | 0.6 | GO:0004750 | ribulose-phosphate 3-epimerase activity(GO:0004750) |
| 0.2 | 4.4 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
| 0.2 | 1.0 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
| 0.2 | 0.6 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.2 | 1.2 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.2 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.2 | 2.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.2 | 0.4 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
| 0.2 | 0.6 | GO:0070975 | FHA domain binding(GO:0070975) |
| 0.2 | 1.0 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.2 | 1.9 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.2 | 3.9 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.2 | 1.3 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) |
| 0.2 | 0.6 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.2 | 0.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.2 | 5.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.2 | 1.1 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.2 | 0.6 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.2 | 1.9 | GO:0089720 | caspase binding(GO:0089720) |
| 0.2 | 0.6 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
| 0.2 | 5.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.2 | 40.7 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.2 | 1.7 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.2 | 5.7 | GO:0005112 | Notch binding(GO:0005112) |
| 0.2 | 2.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.2 | 1.1 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.2 | 4.0 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
| 0.2 | 0.5 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
| 0.2 | 0.5 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.2 | 2.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.2 | 1.6 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.2 | 0.5 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
| 0.2 | 3.0 | GO:0016405 | CoA-ligase activity(GO:0016405) |
| 0.2 | 2.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.2 | 1.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.2 | 0.7 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.2 | 1.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.2 | 0.5 | GO:0008903 | hydroxypyruvate isomerase activity(GO:0008903) |
| 0.2 | 1.6 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.2 | 1.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.2 | 1.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.2 | 6.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.2 | 3.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.2 | 0.3 | GO:0071253 | connexin binding(GO:0071253) |
| 0.2 | 1.7 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.2 | 1.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.2 | 0.7 | GO:0005292 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
| 0.2 | 1.2 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.2 | 2.5 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 0.2 | 0.7 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.2 | 1.0 | GO:0015639 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
| 0.2 | 7.2 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.2 | 0.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.2 | 7.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.2 | 2.3 | GO:0048185 | activin binding(GO:0048185) |
| 0.2 | 1.0 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.2 | 0.3 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
| 0.2 | 1.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.2 | 1.3 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.2 | 4.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.2 | 0.5 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.2 | 1.1 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 0.2 | 1.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.2 | 17.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.2 | 0.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.2 | 0.6 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
| 0.2 | 1.0 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.2 | 0.5 | GO:0099530 | G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential(GO:0099530) |
| 0.2 | 0.5 | GO:0052858 | peptidyl-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0052858) |
| 0.2 | 10.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
| 0.2 | 0.5 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
| 0.2 | 0.5 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
| 0.2 | 1.4 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.2 | 0.8 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
| 0.2 | 8.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.2 | 0.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.2 | 2.3 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.2 | 6.2 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.2 | 0.9 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
| 0.1 | 6.1 | GO:0005521 | lamin binding(GO:0005521) |
| 0.1 | 0.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.1 | 1.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.1 | 4.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.1 | 2.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.1 | 1.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.1 | 0.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.1 | 0.4 | GO:0046403 | polynucleotide 3'-phosphatase activity(GO:0046403) |
| 0.1 | 3.7 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 0.7 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.1 | 3.2 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.1 | 0.7 | GO:0030622 | U4atac snRNA binding(GO:0030622) |
| 0.1 | 4.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.1 | 1.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.1 | 0.6 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.1 | 0.6 | GO:0051500 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.1 | 6.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.1 | 0.6 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
| 0.1 | 1.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.1 | 0.1 | GO:0010736 | serum response element binding(GO:0010736) |
| 0.1 | 0.4 | GO:0003860 | 3-hydroxyisobutyryl-CoA hydrolase activity(GO:0003860) |
| 0.1 | 0.8 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 0.1 | 0.6 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.1 | 0.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.1 | 1.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.1 | 0.4 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
| 0.1 | 3.9 | GO:0043236 | laminin binding(GO:0043236) |
| 0.1 | 0.4 | GO:0030290 | sphingolipid activator protein activity(GO:0030290) beta-N-acetylgalactosaminidase activity(GO:0032428) |
| 0.1 | 1.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 3.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.1 | 2.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.1 | 1.2 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.1 | 7.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.1 | 0.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.1 | 0.7 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 0.1 | 5.2 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.1 | 0.5 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
| 0.1 | 1.6 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.1 | 0.5 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.1 | 0.9 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.1 | 2.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.1 | 4.0 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.1 | 5.4 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.1 | 1.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.1 | 8.0 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.1 | 1.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
| 0.1 | 0.1 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.1 | 1.0 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.1 | 0.9 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.1 | 2.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.1 | 57.0 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.1 | 0.5 | GO:0035514 | DNA demethylase activity(GO:0035514) |
| 0.1 | 0.5 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.1 | 0.4 | GO:0047325 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
| 0.1 | 3.5 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.1 | 3.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.1 | 1.5 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.1 | 0.6 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.1 | 1.0 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.1 | 0.8 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
| 0.1 | 0.5 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.1 | 0.7 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.1 | 0.6 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.1 | 0.7 | GO:0070004 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
| 0.1 | 0.5 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.1 | 0.4 | GO:1904854 | proteasome core complex binding(GO:1904854) |
| 0.1 | 1.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.1 | 0.2 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 0.1 | 0.5 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 0.1 | 6.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.1 | 3.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.1 | 1.7 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.1 | 2.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.1 | 0.5 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.1 | 1.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.1 | 0.3 | GO:0016794 | guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity(GO:0008893) diphosphoric monoester hydrolase activity(GO:0016794) |
| 0.1 | 1.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.1 | 0.5 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.1 | 0.6 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
| 0.1 | 0.3 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.1 | 1.0 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.1 | 0.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.1 | 0.8 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.1 | 7.6 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 2.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 1.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.1 | 0.4 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) |
| 0.1 | 0.8 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.1 | 0.1 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
| 0.1 | 0.6 | GO:0003696 | satellite DNA binding(GO:0003696) |
| 0.1 | 0.2 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.1 | 1.1 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
| 0.1 | 0.7 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.1 | 0.8 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.1 | 0.9 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 0.1 | 1.0 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.1 | 2.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.1 | 1.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.1 | 0.5 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.1 | 0.3 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 0.1 | 2.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.1 | 0.3 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
| 0.1 | 0.2 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
| 0.1 | 1.6 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.1 | 0.6 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.1 | 0.3 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
| 0.1 | 0.2 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.1 | 2.0 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.1 | 0.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.1 | 0.8 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.1 | 0.8 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.1 | 0.3 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.1 | 4.0 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.1 | 1.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.1 | 0.6 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.1 | 0.4 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 0.1 | 0.3 | GO:0008892 | guanine deaminase activity(GO:0008892) |
| 0.1 | 1.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 2.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.1 | 0.5 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) |
| 0.1 | 0.6 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
| 0.1 | 0.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.1 | 0.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 0.1 | 0.9 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.1 | 0.4 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
| 0.1 | 0.3 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.1 | 0.9 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
| 0.1 | 0.7 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
| 0.1 | 0.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.1 | 0.4 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
| 0.1 | 0.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.1 | 0.6 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.1 | 18.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 1.8 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.1 | 3.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.1 | 1.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.1 | 2.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.1 | 0.7 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 0.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.1 | 1.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.1 | 10.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 1.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.1 | 1.1 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
| 0.1 | 0.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.1 | 2.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.1 | 0.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.1 | 0.5 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.1 | 2.0 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 0.1 | 0.3 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 0.1 | 0.3 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 0.1 | 0.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.1 | 1.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.1 | 1.8 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.1 | 1.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.1 | 0.3 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.1 | 0.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.1 | 0.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.1 | 0.9 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 1.3 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.1 | 0.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.1 | 1.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.1 | 0.3 | GO:0070404 | NADH binding(GO:0070404) |
| 0.1 | 0.3 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 0.1 | 0.8 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.1 | 0.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.1 | 2.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.1 | 9.9 | GO:0002039 | p53 binding(GO:0002039) |
| 0.1 | 0.5 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.1 | 0.3 | GO:0098626 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
| 0.1 | 0.1 | GO:0047804 | cysteine-S-conjugate beta-lyase activity(GO:0047804) |
| 0.1 | 0.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.1 | 0.3 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.1 | 0.1 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.1 | 1.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.1 | 0.6 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.1 | 0.8 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
| 0.1 | 1.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.1 | 2.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.1 | 0.3 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.1 | 0.6 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.1 | 0.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.1 | 1.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.1 | 0.4 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.1 | 10.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 0.5 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.1 | 1.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.1 | 1.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 1.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.1 | 0.4 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.1 | 3.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.1 | 0.2 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.1 | 0.2 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.1 | 0.2 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.1 | 0.6 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.1 | 0.3 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
| 0.1 | 2.5 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.1 | 0.4 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.1 | 1.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 1.9 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.1 | 2.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.1 | 0.2 | GO:0070697 | activin receptor binding(GO:0070697) |
| 0.1 | 0.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.1 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 0.1 | 0.4 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.1 | 4.2 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.1 | 0.9 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
| 0.1 | 1.7 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
| 0.1 | 0.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.1 | 2.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.1 | 1.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.1 | 1.1 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.1 | 2.0 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.1 | 1.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.1 | 1.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.1 | 0.5 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.1 | 5.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.1 | 1.2 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.1 | 0.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
| 0.1 | 0.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.1 | 0.2 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
| 0.1 | 0.5 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.1 | 3.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.1 | 0.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.1 | 1.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.1 | 1.6 | GO:0016247 | channel regulator activity(GO:0016247) |
| 0.1 | 1.4 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.1 | 0.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.1 | 0.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.1 | 0.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.1 | 0.3 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.1 | 0.3 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.1 | 1.6 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.1 | 1.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.1 | 0.2 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 0.1 | 0.3 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.1 | 0.5 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
| 0.1 | 0.4 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.1 | 0.4 | GO:0035473 | lipase binding(GO:0035473) |
| 0.1 | 3.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.1 | 0.2 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
| 0.1 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 0.1 | 0.6 | GO:0000829 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) inositol hexakisphosphate kinase activity(GO:0000828) inositol heptakisphosphate kinase activity(GO:0000829) inositol hexakisphosphate 5-kinase activity(GO:0000832) diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
| 0.1 | 0.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.1 | 0.3 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.1 | 14.3 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.1 | 0.3 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.1 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.1 | 0.1 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.1 | 0.3 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.1 | 0.2 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
| 0.1 | 1.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.1 | 1.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.1 | 3.3 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.1 | 1.0 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.1 | 0.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.1 | 0.2 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.1 | 2.7 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
| 0.1 | 0.5 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
| 0.1 | 0.5 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 0.1 | 0.1 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.1 | 1.0 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.1 | 1.0 | GO:0016836 | hydro-lyase activity(GO:0016836) |
| 0.1 | 0.3 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.1 | 0.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.1 | 1.9 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.1 | 0.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.1 | 0.9 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.1 | 1.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.1 | 0.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.1 | 2.6 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.1 | 1.0 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.1 | 0.3 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.1 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.1 | 0.2 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.1 | 0.2 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.1 | 0.8 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.1 | 1.0 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.1 | 1.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.1 | 1.4 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
| 0.0 | 1.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.0 | 0.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.0 | 0.4 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.0 | 0.8 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.0 | 0.1 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.0 | 0.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.0 | 0.8 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.0 | 0.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.0 | 4.2 | GO:0047485 | protein N-terminus binding(GO:0047485) |
| 0.0 | 0.4 | GO:0036122 | BMP binding(GO:0036122) |
| 0.0 | 2.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.0 | 0.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.0 | 0.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.0 | 0.8 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.0 | 1.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.0 | 1.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.0 | 0.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.0 | 0.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.0 | 0.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.0 | 1.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.0 | 19.5 | GO:0030695 | GTPase regulator activity(GO:0030695) |
| 0.0 | 1.8 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
| 0.0 | 2.8 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
| 0.0 | 2.9 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.0 | 0.5 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.0 | 0.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.0 | 0.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.0 | 0.4 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.0 | 0.1 | GO:0004663 | protein geranylgeranyltransferase activity(GO:0004661) Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.0 | 0.1 | GO:0008650 | rRNA (uridine-2'-O-)-methyltransferase activity(GO:0008650) rRNA (uridine) methyltransferase activity(GO:0016436) |
| 0.0 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.0 | 1.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.0 | 1.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.0 | 0.2 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.0 | 2.6 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.0 | 0.4 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
| 0.0 | 2.3 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.0 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.0 | 0.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.0 | 15.1 | GO:0003779 | actin binding(GO:0003779) |
| 0.0 | 5.2 | GO:0020037 | heme binding(GO:0020037) |
| 0.0 | 0.2 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.0 | 0.3 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.0 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.0 | 2.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.0 | 0.3 | GO:1901981 | phosphatidylinositol phosphate binding(GO:1901981) |
| 0.0 | 1.8 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.0 | 0.2 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.0 | 0.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.0 | 0.1 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
| 0.0 | 0.1 | GO:0033749 | histone demethylase activity (H3-R2 specific)(GO:0033746) histone demethylase activity (H4-R3 specific)(GO:0033749) |
| 0.0 | 0.4 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.0 | 9.6 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
| 0.0 | 0.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.0 | 3.3 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
| 0.0 | 0.8 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.0 | 0.2 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.0 | 0.1 | GO:1990239 | steroid hormone binding(GO:1990239) |
| 0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.0 | 1.1 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.0 | 0.2 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.0 | 0.1 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
| 0.0 | 0.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.0 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 0.0 | 0.3 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.0 | 0.2 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.0 | 6.3 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
| 0.0 | 0.1 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
| 0.0 | 1.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.0 | 0.5 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
| 0.0 | 1.4 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.0 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.0 | 2.4 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.0 | 0.2 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
| 0.0 | 0.2 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
| 0.0 | 1.1 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.0 | 0.4 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.0 | 0.2 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.0 | 0.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 0.0 | 1.1 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.0 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
| 0.0 | 0.1 | GO:0047718 | androsterone dehydrogenase activity(GO:0047023) indanol dehydrogenase activity(GO:0047718) |
| 0.0 | 0.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 0.0 | 0.2 | GO:1902444 | riboflavin binding(GO:1902444) |
| 0.0 | 0.3 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.0 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.0 | 0.1 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.0 | 0.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.0 | 14.9 | GO:0005198 | structural molecule activity(GO:0005198) |
| 0.0 | 0.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.0 | 0.3 | GO:0030553 | cGMP binding(GO:0030553) |
| 0.0 | 0.2 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.0 | 0.1 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
| 0.0 | 0.1 | GO:0004341 | gluconolactonase activity(GO:0004341) |
| 0.0 | 0.1 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
| 0.0 | 1.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
| 0.0 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
| 0.0 | 0.1 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.0 | 0.1 | GO:1990175 | EH domain binding(GO:1990175) |
| 0.0 | 0.1 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.0 | 0.4 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.0 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.0 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.0 | 0.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.0 | 0.3 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.0 | 0.2 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
| 0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.0 | 0.6 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.0 | 0.2 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.0 | 0.1 | GO:0019166 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.0 | 0.1 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.0 | 0.1 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.0 | 0.1 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.0 | 0.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.0 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.0 | 0.1 | GO:0043531 | ADP binding(GO:0043531) |
| 0.0 | 0.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.0 | 0.3 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.0 | 0.2 | GO:0010181 | FMN binding(GO:0010181) |
| 0.0 | 0.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.0 | 0.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.0 | 0.1 | GO:0000252 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity(GO:0047012) |
| 0.0 | 1.3 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
| 0.0 | 0.3 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.0 | 0.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.0 | 0.1 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
| 0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.0 | 0.1 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) |
| 0.0 | 0.7 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.0 | 0.1 | GO:0030305 | heparanase activity(GO:0030305) |
| 0.0 | 1.3 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.0 | 0.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.0 | 0.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.0 | 0.3 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
| 0.0 | 0.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.0 | 0.1 | GO:0016429 | tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 0.0 | 4.2 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
| 0.0 | 0.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.0 | 1.2 | GO:0008238 | exopeptidase activity(GO:0008238) |
| 0.0 | 0.7 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.0 | 0.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.0 | 0.0 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 0.0 | 0.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.0 | 0.0 | GO:0052816 | medium-chain acyl-CoA hydrolase activity(GO:0052815) long-chain acyl-CoA hydrolase activity(GO:0052816) |
| 0.0 | 0.6 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.0 | 0.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.0 | 0.1 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 0.0 | 0.2 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.0 | 0.0 | GO:0036055 | protein-malonyllysine demalonylase activity(GO:0036054) protein-succinyllysine desuccinylase activity(GO:0036055) protein-glutaryllysine deglutarylase activity(GO:0061697) |
| 0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.0 | 0.1 | GO:0048038 | quinone binding(GO:0048038) |
| 0.0 | 0.2 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
| 0.0 | 0.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.0 | 0.1 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
| 0.0 | 0.3 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.0 | 0.0 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
| 0.0 | 0.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.0 | 0.7 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.0 | 0.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.0 | 0.2 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.0 | 0.0 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.0 | 0.1 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
| 0.0 | 0.0 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
| 0.0 | 0.0 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.0 | 0.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 10.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.4 | 1.6 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.4 | 0.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.4 | 12.4 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.4 | 1.8 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.3 | 19.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.3 | 14.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.3 | 0.6 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.3 | 10.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.3 | 28.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.3 | 5.0 | PID FOXO PATHWAY | FoxO family signaling |
| 0.3 | 14.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.3 | 6.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.3 | 12.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.2 | 5.4 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.2 | 4.6 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.2 | 6.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.2 | 5.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.2 | 8.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.2 | 17.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.2 | 15.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.2 | 6.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.2 | 10.0 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.2 | 2.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.2 | 4.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.2 | 6.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.2 | 9.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.2 | 2.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.2 | 6.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.2 | 7.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.2 | 6.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.2 | 1.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.2 | 3.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.2 | 4.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.2 | 10.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.2 | 1.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.2 | 5.2 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.1 | 16.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.1 | 3.9 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.1 | 13.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.1 | 4.4 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.1 | 10.0 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.1 | 1.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.1 | 8.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.1 | 3.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 1.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.1 | 2.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.1 | 2.0 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.1 | 2.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.1 | 14.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.1 | 2.8 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.1 | 1.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.1 | 2.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 2.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.1 | 8.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.1 | 6.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.1 | 6.0 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.1 | 1.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 8.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 5.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 3.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 4.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.1 | 6.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 3.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.1 | 1.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.1 | 0.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.1 | 1.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.1 | 6.7 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.1 | 2.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.1 | 3.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 4.7 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.1 | 7.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.1 | 5.5 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.1 | 3.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.1 | 16.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.1 | 3.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.1 | 4.6 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.1 | 2.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.1 | 1.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.1 | 0.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 1.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.1 | 2.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.1 | 0.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 3.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.1 | 0.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.1 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.1 | 1.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.1 | 5.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.1 | 19.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 7.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.1 | 0.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.1 | 1.3 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.1 | 1.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.1 | 0.4 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.1 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.1 | 3.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 3.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.1 | 4.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.1 | 4.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.1 | 2.9 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.1 | 0.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.1 | 0.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.0 | 0.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.0 | 1.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.0 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.0 | 1.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.0 | 0.3 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.0 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.0 | 0.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 0.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 1.3 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.0 | 0.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.0 | 1.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.0 | 1.0 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.0 | 0.3 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.0 | 0.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.0 | 0.2 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.0 | 0.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.0 | 5.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 0.3 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.0 | 0.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 0.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 22.9 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.7 | 6.6 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.6 | 1.1 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
| 0.5 | 1.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.5 | 10.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.4 | 1.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.4 | 10.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.4 | 9.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.4 | 1.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.4 | 10.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.3 | 1.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.3 | 2.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.3 | 14.2 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.3 | 2.8 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.3 | 2.2 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
| 0.3 | 4.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.3 | 7.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.3 | 5.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.3 | 1.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.3 | 6.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.3 | 17.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.3 | 15.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.2 | 11.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.2 | 6.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.2 | 10.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.2 | 2.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
| 0.2 | 7.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.2 | 3.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.2 | 12.9 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
| 0.2 | 0.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.2 | 8.5 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.2 | 15.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.2 | 11.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.2 | 4.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.2 | 6.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.2 | 1.7 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.2 | 6.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.2 | 9.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.2 | 2.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.2 | 2.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.2 | 1.0 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.2 | 4.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.2 | 14.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.2 | 7.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.2 | 1.2 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.2 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.2 | 2.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.2 | 10.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.2 | 8.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.2 | 3.4 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.2 | 1.6 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.2 | 7.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.2 | 5.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.2 | 4.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.2 | 1.7 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.2 | 1.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.2 | 3.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.2 | 1.8 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.2 | 6.0 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.2 | 4.5 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 0.2 | 13.0 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
| 0.2 | 4.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.2 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.2 | 6.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.2 | 5.8 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.2 | 6.0 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.2 | 0.3 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
| 0.2 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.1 | 0.4 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
| 0.1 | 7.3 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.1 | 5.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.1 | 4.6 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
| 0.1 | 1.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.1 | 2.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.1 | 4.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.1 | 1.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.1 | 5.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.1 | 2.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.1 | 3.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.1 | 13.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.1 | 0.3 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
| 0.1 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.1 | 3.7 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.1 | 3.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 3.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.1 | 1.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.1 | 9.9 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.1 | 0.1 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
| 0.1 | 3.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.1 | 4.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 4.5 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.1 | 1.9 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
| 0.1 | 1.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.1 | 20.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 0.1 | 1.8 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.1 | 1.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.1 | 3.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.1 | 12.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 6.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.1 | 3.9 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.1 | 9.5 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.1 | 1.3 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
| 0.1 | 3.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 1.2 | REACTOME MAP KINASE ACTIVATION IN TLR CASCADE | Genes involved in MAP kinase activation in TLR cascade |
| 0.1 | 4.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.1 | 0.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.1 | 3.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.1 | 1.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.1 | 14.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.1 | 0.3 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.1 | 2.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 2.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.1 | 2.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.1 | 1.5 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.1 | 1.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.1 | 2.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.1 | 5.3 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.1 | 1.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.1 | 1.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.1 | 0.1 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
| 0.1 | 0.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.1 | 1.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.1 | 0.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.1 | 3.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 1.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 5.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.1 | 0.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.1 | 4.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 2.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.1 | 0.1 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
| 0.1 | 0.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
| 0.1 | 1.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 0.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.1 | 0.2 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
| 0.1 | 1.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.0 | 1.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.0 | 0.6 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.0 | 2.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.0 | 1.9 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.0 | 0.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.0 | 2.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.0 | 1.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.0 | 1.2 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.0 | 1.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.0 | 1.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.0 | 0.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.0 | 0.4 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.0 | 2.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 4.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 0.0 | 4.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.0 | 5.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
| 0.0 | 4.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 7.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 7.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.0 | 0.1 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
| 0.0 | 0.9 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.0 | 0.7 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 0.0 | 1.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.0 | 0.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.0 | 2.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.0 | 0.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.0 | 0.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.0 | 1.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.0 | 7.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.0 | 2.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.0 | 0.2 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
| 0.0 | 0.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.0 | 0.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.0 | 0.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.0 | 1.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.0 | 0.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.0 | 1.7 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.0 | 0.5 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
| 0.0 | 0.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.0 | 0.1 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
| 0.0 | 2.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 5.0 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.0 | 0.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.0 | 0.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.0 | 0.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.0 | 1.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 0.0 | 0.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.0 | 0.9 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.0 | 1.0 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.0 | 1.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 0.5 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 0.0 | 0.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
| 0.0 | 0.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.0 | 1.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |